{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:07:52Z","timestamp":1793844472959,"version":"4.6.1"},"reference-count":699,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Netherlands Organisation for Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010374","name":"Stichting Blindenhulp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010302","name":"Algemene Nederlandse Vereniging ter voorkoming van Blindheid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023687","name":"Stichting Leids Oogheelkundig Ondersteuningsfonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010321","name":"Maculafonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010330","name":"Stichting Retina Fonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001717","name":"Leiden University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010331","name":"Stichting voor Ooglijders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010372","name":"Rotterdamse Stichting Blindenbelangen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010372","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010373","name":"Stichting Blinden-Penning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.preteyeres.2024.101236","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T11:10:54Z","timestamp":1706785854000},"page":"101236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":138,"special_numbering":"C","title":["Central serous chorioretinopathy: An evidence-based treatment guideline"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3106-0455","authenticated-orcid":false,"given":"Helena M.A.","family":"Feenstra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elon H.C.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chui Ming Gemmy","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Ohno-Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Y.Y.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Querques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Downes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Yzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Breazzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousif","family":"Subhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Tadayoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried G.","family":"Priglinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurenz J.B.","family":"Pauleikhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens A.K.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Loewenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roselie M.H.","family":"Diederen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinier O.","family":"Schlingemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel B.","family":"Hoyng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay K.","family":"Chhablani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank G.","family":"Holz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobha","family":"Sivaprasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Lotery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence A.","family":"Yannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Bailey","family":"Freund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camiel J.F.","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2024.101236_bib1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fendo.2016.00154","article-title":"Choroidal and retinal abnormalities by optical coherence tomography in endogenous cushing's syndrome","volume":"7","author":"Abalem","year":"2016","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib2","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2147\/OPTH.S87499","article-title":"Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy","volume":"9","author":"Abd Elhamid","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1089\/jop.2014.0173","article-title":"Treatment of chronic central serous chorioretinopathy with oral methotrexate","volume":"31","author":"Abrishami","year":"2015","journal-title":"J. Ocul. Pharmacol. Therap."},{"key":"10.1016\/j.preteyeres.2024.101236_bib4","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1097\/IAE.0000000000001040","article-title":"Choroidal vascularity index in central serous chorioretinopathy","volume":"36","author":"Agrawal","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/IAE.0000000000000699","article-title":"Nodular posterior scleritis: clinico-sonographic characteristics and proposed diagnostic criteria","volume":"36","author":"Agrawal","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00006982-198400440-00011","article-title":"Choroidal rupture. A histopathologic study of 47 cases","volume":"4","author":"Aguilar","year":"1984","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000333824","article-title":"Should central serous chorioretinopathy be added to the list of ocular side effects of phosphodiesterase 5 inhibitors?","volume":"227","author":"Aliferis","year":"2012","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2024.101236_bib8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.joco.2019.06.006","article-title":"Intravitreal bevacizumab administration for the treatment of chronic central serous chorioretinopathy","volume":"31","author":"Alishiri","year":"2019","journal-title":"J. Curr. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib9","first-page":"96","article-title":"Topical nepafenac in treatment of acute central serous chorioretinopathy","volume":"2","author":"Alkin","year":"2013","journal-title":"Med. Hypothesis, Discovery Innov. Ophthalmol. J."},{"key":"10.1016\/j.preteyeres.2024.101236_bib10","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2147\/OPTH.S58617","article-title":"Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy","volume":"8","author":"Alkin","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib11","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s10103-020-03225-6","article-title":"Optical coherence tomography parameters as predictors of treatment response to a 577-nm subthreshold micropulse laser in chronic central serous chorioretinopathy","volume":"36","author":"Alt\u0131nel","year":"2021","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib12","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.2147\/OPTH.S112431","article-title":"Microsecond yellow laser for subfoveal leaks in central serous chorioretinopathy","volume":"10","author":"Ambiya","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/2515841420945107","article-title":"Role of 532 nm transfoveal subthreshold micropulse laser in non-resolving central serous chorioretinopathy with subfoveal leaks","volume":"12","author":"Ambiya","year":"2020","journal-title":"Therap. Adv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib14","article-title":"Navigated micropulse laser for central serous chorioretinopathy: efficacy, safety, and predictive factors of treatment response","author":"Amoroso","year":"2021","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244469","article-title":"Diagnosis of central serous chorioretinopathy by deep learning analysis of en face images of choroidal vasculature: a pilot study","volume":"16","author":"Aoyama","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.preteyeres.2024.101236_bib16","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ng.938","article-title":"Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population","volume":"43","author":"Arakawa","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.preteyeres.2024.101236_bib17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/0301-4738.154380","article-title":"Choroidal metastases: origin, features, and therapy","volume":"63","author":"Arepalli","year":"2015","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10792-016-0286-4","article-title":"Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment","volume":"37","author":"Arf","year":"2017","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/ICB.0b013e3182733d6b","article-title":"The seasick choroid: a finding on enhanced depth imaging spectral-domain optical coherence tomography of choroidal lymphoma","volume":"7","author":"Arias","year":"2013","journal-title":"Retin. Cases Brief Rep.."},{"key":"10.1016\/j.preteyeres.2024.101236_bib20","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/aos.13838","article-title":"Isolated pigment epithelium detachment: evidence for relation to central serous chorioretinopathy and effect of photodynamic therapy","volume":"96","author":"Arif","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib21","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ajo.2003.11.059","article-title":"Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-tap and vip report no. 3","volume":"137","author":"Arnold","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib22","article-title":"Implementation of the new multimodal imaging-based classification of central serous chorioretinopathy","author":"Arora","year":"2021","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib23","article-title":"Visual acuity correlates with multimodal imaging-based categories of central serous chorioretinopathy","author":"Arora","year":"2021","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib24","article-title":"One year outcome and predictors of treatment outcome in central serous chorioretinopathy: multimodal imaging based analysis","author":"Arora","year":"2021","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cxo.12818","article-title":"Subthreshold diode micropulse laser versus observation in acute central serous chorioretinopathy","volume":"102","author":"Arora","year":"2018","journal-title":"Clin. Exp. Optometry"},{"key":"10.1016\/j.preteyeres.2024.101236_bib26","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s40123-022-00543-6","article-title":"Brachytherapy for central serous chorioretinopathy","volume":"11","author":"Arora","year":"2022","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.preteyeres.2024.101236_bib27","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/eye.2017.293","article-title":"Visual outcomes and anatomic changes after sub-threshold micropulse yellow laser (577-nm) treatment for chronic central serous chorioretinopathy: long-term follow-up","volume":"32","author":"Arsan","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib28","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.2217\/rme-2020-0056","article-title":"Treatment of resistant chronic central serous chorioretinopathy via platelet-rich plasma with electromagnetic stimulation","volume":"15","author":"Arslan","year":"2020","journal-title":"Regen. Med."},{"key":"10.1016\/j.preteyeres.2024.101236_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/02713680903428306","article-title":"Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study","volume":"35","author":"Artunay","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/jovr.jovr_9_17","article-title":"Subthreshold continuous wave autofluorescence-controlled laser treatment of chronic central serous chorioretinopathy","volume":"13","author":"Ashraf","year":"2018","journal-title":"J. Ophthal. Vis. Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/jop.2012.0072","article-title":"The efficacy of intravitreal bevacizumab for acute central serous chorioretinopathy","volume":"29","author":"Aydin","year":"2013","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.preteyeres.2024.101236_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-200402000-00001","volume":"24","author":"Azab","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib33","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2013.09.024","article-title":"Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial","volume":"121","author":"Bae","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib34","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajo.2011.04.008","article-title":"A randomized pilot study of low-fluence photodynamic therapy versus intravitreal ranibizumab for chronic central serous chorioretinopathy","volume":"152","author":"Bae","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib35","first-page":"118","article-title":"Prevalence of helicobacter pylori infection in patients with central serous chorioretinopathy: a review","volume":"6","author":"Bagheri","year":"2017","journal-title":"Med. Hypoth., Discovery Innov. Ophthalmol. J."},{"key":"10.1016\/j.preteyeres.2024.101236_bib36","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2147\/OPTH.S202047","article-title":"Treatment of central serous chorioretinopathy with topical nsaids","volume":"13","author":"Bahadorani","year":"2019","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ajo.2012.09.018","article-title":"Serous macular detachment in waldenstrom macroglobulinemia: a report of four cases","volume":"155","author":"Baker","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib38","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ophtha.2016.03.017","article-title":"Bullous variant of central serous chorioretinopathy: expansion of phenotypic features using multimethod imaging","volume":"123","author":"Balaratnasingam","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1442-9071.2005.01027.x","article-title":"Long-term macular function in eyes with central serous chorioretinopathy","volume":"33","author":"Baran","year":"2005","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ophtha.2017.07.020","article-title":"Idiopathic acute exudative polymorphous vitelliform maculopathy: clinical spectrum and multimodal imaging characteristics","volume":"125","author":"Barbazetto","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib41","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/bjophthalmol-2017-311612","article-title":"Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis","volume":"102","author":"Barry","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib42","first-page":"1131","article-title":"In patients suffering from idiopathic central serous chorioretinopathy, anxiety scores are higher than in healthy controls, but do not vary according to sex or repeated central serous chorioretinopathy","volume":"11","author":"Bazzazi","year":"2015","journal-title":"Neuropsychiatr. Disease Treat."},{"key":"10.1016\/j.preteyeres.2024.101236_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/archopht.122.1.121","article-title":"Is coxsackievirus the cause of unilateral acute idiopathic maculopathy?","volume":"122","author":"Beck","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib44","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s00347-012-2688-7","article-title":"[treatment of central serous chorioretinopathy: micropulse photocoagulation versus bevacizumab]","volume":"109","author":"Beger","year":"2012","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.preteyeres.2024.101236_bib45","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/IAE.0b013e3182670fa3","article-title":"Improvement in visual acuity and contrast sensitivity in patients with central serous chorioretinopathy after macular subthreshold laser therapy","volume":"33","author":"Behnia","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib46","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0002-9394(02)01694-X","article-title":"Macular infarction after transpupillary thermotherapy for subfoveal choroidal neovascularization in age-related macular degeneration","volume":"134","author":"Benner","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib47","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/bjo.39.10.605","article-title":"Central serous retinopathy","volume":"39","author":"Bennett","year":"1955","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.preteyeres.2018.12.003","article-title":"On the origin of proteins in human drusen: the meet, greet and stick hypothesis","volume":"70","author":"Bergen","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib49","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.mam.2012.04.005","article-title":"Understanding age-related macular degeneration (amd): relationships between the photoreceptor\/retinal pigment epithelium\/bruch's membrane\/choriocapillaris complex","volume":"33","author":"Bhutto","year":"2012","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.preteyeres.2024.101236_bib50","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/IAE.0b013e3181c596f8","article-title":"Subretinal fluid in acute posterior multifocal placoid pigment epitheliopathy","volume":"30","author":"Birnbaum","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib51","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0002-9440(10)65138-3","article-title":"Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation","volume":"155","author":"Blaauwgeers","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib52","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ajo.2019.05.010","article-title":"Optic disc pit maculopathy: new perspectives on the natural history","volume":"207","author":"Bloch","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-0031-1299165","article-title":"New guidelines in the treatment of persistent central serous chorioretinopathy: pdt with half-dose verteporfin","volume":"229","author":"Boni","year":"2012","journal-title":"Klinisch. Monatsbl. Augenheilk."},{"key":"10.1016\/j.preteyeres.2024.101236_bib54","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/jamaophthalmol.2015.1320","article-title":"Association of choroidal neovascularization and central serous chorioretinopathy with optical coherence tomography angiography","volume":"133","author":"Bonini Filho","year":"2015","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib55","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.preteyeres.2008.01.002","article-title":"The spectrum of retinal dystrophies caused by mutations in the peripherin\/rds gene","volume":"27","author":"Boon","year":"2008","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib56","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ophtha.2008.12.019","article-title":"Central areolar choroidal dystrophy","volume":"116","author":"Boon","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.preteyeres.2009.04.002","article-title":"The spectrum of ocular phenotypes caused by mutations in the best1 gene","volume":"28","author":"Boon","year":"2009","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib58","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ophtha.2012.09.057","article-title":"Autosomal recessive bestrophinopathy: differential diagnosis and treatment options","volume":"120","author":"Boon","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib59","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9394(01)01341-1","article-title":"Verteporfin infusion-associated pain","volume":"133","author":"Borodoker","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2018.07.002","article-title":"Angiography and evaluation of the choroid and choroidal vascular disorders","author":"Borrelli","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8091271","article-title":"Optical coherence tomography parameters as predictors of treatment response to eplerenone in central serous chorioretinopathy","volume":"8","author":"Borrelli","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2024.101236_bib62","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1097\/IAE.0000000000000614","article-title":"Spironolactone for nonresolving central serous chorioretinopathy: a randomized controlled crossover study","volume":"35","author":"Bousquet","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib63","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1097\/IAE.0b013e318297a07a","article-title":"Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study","volume":"33","author":"Bousquet","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajo.2016.02.012","article-title":"Shift work: a risk factor for central serous chorioretinopathy","volume":"165","author":"Bousquet","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib65","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajo.2018.09.034","article-title":"Predictive factors of response to mineralocorticoid receptor antagonists in nonresolving central serous chorioretinopathy","volume":"198","author":"Bousquet","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib66","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archopht.1993.01090090081024","article-title":"Central serous chorioretinopathy in endogenous hypercortisolism","volume":"111","author":"Bouzas","year":"1993","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib67","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.oret.2020.06.006","article-title":"Prospective impact of sildenafil on chronic central serous chorioretinopathy: pisces trial","volume":"4","author":"Breazzano","year":"2020","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib68","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/OPTH.S115685","article-title":"Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life","volume":"11","author":"Breukink","year":"2017","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib69","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/OPTH.S115685","article-title":"Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life","volume":"11","author":"Breukink","year":"2017","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib70","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/aos.13059","article-title":"Efficacy of photodynamic therapy in steroid-associated chronic central serous chorioretinopathy: a case-control study","volume":"94","author":"Breukink","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib71","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/aos.12938","article-title":"Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol","volume":"94","author":"Breukink","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib72","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1167\/iovs.15-17343","article-title":"Genomic copy number variations of the complement component c4b gene are associated with chronic central serous chorioretinopathy","volume":"56","author":"Breukink","year":"2015","journal-title":"Investig. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib73","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1167\/iovs.18-25054","article-title":"The effect of corticosteroids on human choroidal endothelial cells: a model to study central serous chorioretinopathy","volume":"59","author":"Brinks","year":"2018","journal-title":"Investig. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib74","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1210\/clinem\/dgab670","article-title":"The cortisol response of male and female choroidal endothelial cells: implications for central serous chorioretinopathy","volume":"107","author":"Brinks","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.preteyeres.2024.101236_bib75","article-title":"Exploring the choroidal vascular labyrinth and its molecular and structural roles in health and disease","author":"Brinks","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib76","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/aos.15112","article-title":"Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities","volume":"100","author":"Brinks","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib77","doi-asserted-by":"crossref","first-page":"e2213","DOI":"10.1210\/clinem\/dgab910","article-title":"Response to letter to the editor from behar-cohen et al.: the cortisol response of male and female choroidal endothelial cells: implications for central serous chorioretinopathy","volume":"107","author":"Brinks","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.preteyeres.2024.101236_bib78","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1159\/000526052","article-title":"Sex hormones in males and females with active central serous chorioretinopathy","volume":"245","author":"Brinks","year":"2022","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2024.101236_bib79","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1038\/s41598-021-82536-2","article-title":"Central serous chorioretinopathy in active endogenous cushing's syndrome","volume":"11","author":"Brinks","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib80","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/iovs.08-1779","article-title":"In vivo human choroidal thickness measurements: evidence for diurnal fluctuations","volume":"50","author":"Brown","year":"2009","journal-title":"Investig. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib81","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0002-9394(14)73483-X","article-title":"Nadolol in the treatment of central serous retinopathy","volume":"116","author":"Browning","year":"1993","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib82","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0161-6420(97)30262-0","article-title":"Laser photocoagulation for persistent central serous retinopathy: results of long-term follow-up","volume":"104","author":"Burumcek","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib83","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00417-020-04999-9","article-title":"Selective retina therapy (srt) in patients with therapy refractory persistent acute central serous chorioretinopathy (csc): 3 months functional and morphological results","volume":"259","author":"B\u00fcttner","year":"2021","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib84","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2147\/OPTH.S12583","article-title":"Low-dose aspirin as treatment for central serous chorioretinopathy","volume":"4","author":"Caccavale","year":"2010","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib85","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.med.48.1.129","article-title":"Ru486 (mifepristone): mechanisms of action and clinical uses","volume":"48","author":"Cadepond","year":"1997","journal-title":"Annual review of medicine"},{"key":"10.1016\/j.preteyeres.2024.101236_bib86","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ajo.2013.06.032","article-title":"Morphologic characterization of dome-shaped macula in myopic eyes with serous macular detachment","volume":"156","author":"Caillaux","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib87","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/ICB.0b013e318196b206","article-title":"Effect of ocular contusion in a patient with chronic central serous chorioretinopathy","volume":"4","author":"Cardillo Piccolino","year":"2010","journal-title":"Retin. Cases Brief Rep."},{"issue":"Pt 3","key":"10.1016\/j.preteyeres.2024.101236_bib88","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/eye.1995.63","article-title":"Indocyanine green angiographic findings in central serous chorioretinopathy","volume":"9","author":"Cardillo Piccolino","year":"1995","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib89","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/IAE.0b013e318175421f","article-title":"Risk factors for posterior cystoid retinal degeneration in central serous chorioretinopathy","volume":"28","author":"Cardillo Piccolino","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib90","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ajo.2004.08.037","article-title":"The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy","volume":"139","author":"Cardillo Piccolino","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib91","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/00006982-200312000-00002","article-title":"Photodynamic therapy for chronic central serous chorioretinopathy","volume":"23","author":"Cardillo Piccolino","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib92","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1167\/iovs.18-23995","article-title":"Choroidal vascular reactivity in central serous chorioretinopathy","volume":"59","author":"Cardillo Piccolino","year":"2018","journal-title":"Investig. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib93","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/S0161-6420(02)01117-X","article-title":"Corticosteroids and central serous chorioretinopathy","volume":"109","author":"Carvalho-Recchia","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib94","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000444328","article-title":"Short-term retinal sensitivity and metamorphopsia changes following half-fluence photodynamic therapy in central serous chorioretinopathy","volume":"56","author":"Casalino","year":"2016","journal-title":"Ophthal. Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib95","first-page":"379","volume":"vol. 81","author":"Castro-Correia","year":"1992"},{"key":"10.1016\/j.preteyeres.2024.101236_bib96","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ajo.2005.02.053","article-title":"Characterization of macular edema from various etiologies by optical coherence tomography","volume":"140","author":"Catier","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib97","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5935\/0004-2749.20160004","article-title":"Serous retinal detachment in patients with macular edema secondary to branch retinal vein occlusion","volume":"79","author":"Celik","year":"2016","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.preteyeres.2024.101236_bib98","first-page":"1444","article-title":"Clinical research of fenofibrate and spironolactone for acute central serous chorioretinopathy","volume":"9","author":"Chai","year":"2016","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib99","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.ophtha.2008.04.014","article-title":"Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial","volume":"115","author":"Chan","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib100","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ajo.2007.02.039","article-title":"Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin","volume":"143","author":"Chan","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib101","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1136\/bjo.87.12.1453","article-title":"Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level","volume":"87","author":"Chan","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib102","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/IAE.0000000000002583","article-title":"Difference between pachychoroid and nonpachychoroid polypoidal choroidal vasculopathy and their response to anti-vascular endothelial growth factor therapy","volume":"40","author":"Chang","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib103","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1080\/02713683.2016.1276196","article-title":"Risk factors for central serous chorioretinopathy: multivariate approach in a case-control study","volume":"42","author":"Chatziralli","year":"2017","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IAE.0000000000002327","article-title":"Angioid streaks: a comprehensive review from pathophysiology to treatment","volume":"39","author":"Chatziralli","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/ph13110336","article-title":"Oral treatment of central serous chorioretinopathy patients using propranolol tablets","volume":"13","author":"Chen","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.preteyeres.2024.101236_bib106","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.ophtha.2008.08.026","article-title":"Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage","volume":"115","author":"Chen","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib107","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","article-title":"Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management","volume":"125","author":"Cheung","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib108","article-title":"Pachychoroid disease","author":"Cheung","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib109","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41433-018-0158-4","article-title":"Pachychoroid disease","volume":"33","author":"Cheung","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib110","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00417-021-05452-1","article-title":"Validation of central serous chorioretinopathy multimodal imaging-based classification system","volume":"260","author":"Chhablani","year":"2022","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib111","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.oret.2020.07.026","article-title":"Multimodal imaging-based central serous chorioretinopathy classification","volume":"4","author":"Chhablani","year":"2020","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib112","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40942-021-00335-3","article-title":"Safety of various parameter sets with navigated microsecond pulsing laser in central serous chorioretinopathy","volume":"7","author":"Chhablani","year":"2021","journal-title":"Int. J. Retina Vitreous"},{"key":"10.1016\/j.preteyeres.2024.101236_bib113","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1097\/IAE.0000000000000655","article-title":"Outcomes of treatment of choroidal neovascularization associated with central serous chorioretinopathy with intravitreal antiangiogenic agents","volume":"35","author":"Chhablani","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib114","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/IAE.0000000000000804","article-title":"Antiangiogenics in choroidal neovascularization associated with laser in central serous chorioretinopathy","volume":"36","author":"Chhablani","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib115","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2147\/OPTH.S67025","article-title":"Navigated focal laser photocoagulation for central serous chorioretinopathy","volume":"8","author":"Chhablani","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib116","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2147\/OPTH.S86778","article-title":"Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy","volume":"9","author":"Chin","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib117","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.preteyeres.2015.02.001","article-title":"Adult-onset foveomacular vitelliform dystrophy: a fresh perspective","volume":"47","author":"Chowers","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib118","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5507\/bp.2013.015","article-title":"Treatment of central serous chorioretinopathy with beta-blocker metipranolol","volume":"159","author":"Chrapek","year":"2015","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky, Olomouc, Czechoslovakia"},{"key":"10.1016\/j.preteyeres.2024.101236_bib119","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000484100","article-title":"Angiographic and tomographic prognostic factors of chronic central serous chorioretinopathy treated with half-dose photodynamic therapy","volume":"240","author":"Chung","year":"2018","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2024.101236_bib120","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/IAE.0000000000001345","article-title":"Focal choroidal excavation and its association with pachychoroid spectrum disorders: a review of the literature and multimodal imaging findings","volume":"37","author":"Chung","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib121","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/eye.2013.236","article-title":"Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review","volume":"27","author":"Chung","year":"2013","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib122","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2174\/156802608784535011","article-title":"Glucocorticoid receptor antagonists","volume":"8","author":"Clark","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.preteyeres.2024.101236_bib123","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0161-6420(98)91024-7","article-title":"Macular serous retinal detachment caused by subretinal leakage in tilted disc syndrome","volume":"105","author":"Cohen","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib124","article-title":"Central serous chorioretinopathy treatment with a systemic pde5 and pde6 inhibitor (sildenafil)","volume":"21","author":"Coleman","year":"2021","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib125","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0002-9394(86)90761-0","article-title":"Ultrasonic hyperthermia and radiation in the management of intraocular malignant melanoma","volume":"101","author":"Coleman","year":"1986","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib126","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/631687","article-title":"Temperament and character personality profile and illness-related stress in central serous chorioretinopathy","volume":"2014","author":"Conrad","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.preteyeres.2024.101236_bib127","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1124\/dmd.31.11.1448","article-title":"Pharmacokinetics and metabolism of [14c]eplerenone after oral administration to humans","volume":"31","author":"Cook","year":"2003","journal-title":"Drug Metabol. Dispos.: Biol. Fate Chem."},{"key":"10.1016\/j.preteyeres.2024.101236_bib128","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1167\/iovs.14-16236","article-title":"Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration","volume":"56","author":"Coscas","year":"2015","journal-title":"Investig. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib129","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2047-783X-17-22","article-title":"Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy","volume":"17","author":"Cuevas","year":"2012","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib130","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ophtha.2009.12.002","article-title":"Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: age-related eye disease study report no. 28","volume":"117","author":"Cukras","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib131","article-title":"Multimodal imaging of macular choroidal macrovessel: a report of two cases","author":"Dalvin","year":"2018","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib132","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/TCRM.S50407","article-title":"The effect of eradicating helicobacter pylori on idiopathic central serous chorioretinopathy patients","volume":"9","author":"Dang","year":"2013","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.preteyeres.2024.101236_bib133","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/TCRM.S54213","article-title":"Subfoveal choroidal thickness after photodynamic therapy in patients with acute idiopathic central serous chorioretinopathy","volume":"10","author":"Dang","year":"2014","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.preteyeres.2024.101236_bib134","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1445-2197.1991.tb00230.x","article-title":"A history of photodynamic therapy","volume":"61","author":"Daniell","year":"1991","journal-title":"Austr. New Zealand J. Surg."},{"key":"10.1016\/j.preteyeres.2024.101236_bib135","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/IAE.0000000000000742","article-title":"En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography","volume":"36","author":"Dansingani","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib136","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","article-title":"Central serous chorioretinopathy: recent findings and new physiopathology hypothesis","volume":"48","author":"Daruich","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib137","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.5.2.2","article-title":"Oral mineralocorticoid-receptor antagonists: real-life experience in clinical subtypes of nonresolving central serous chorioretinopathy with chronic epitheliopathy","volume":"5","author":"Daruich","year":"2016","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib138","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1097\/IAE.0000000000001443","article-title":"Acute central serous chorioretinopathy: factors influencing episode duration","volume":"37","author":"Daruich","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib139","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/eye.2012.191","article-title":"Adverse ophthalmic reaction in poppers users: case series of 'poppers maculopathy'","volume":"26","author":"Davies","year":"2012","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib140","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ophtha.2015.01.029","article-title":"Spectral-domain optical coherence tomography angiography of choroidal neovascularization","volume":"122","author":"de Carlo","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib141","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ophtha.2014.09.026","article-title":"Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration","volume":"122","author":"de Jong","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib142","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1046\/j.1523-1755.2000.00983.x","article-title":"Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology","volume":"57","author":"Delyani","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.preteyeres.2024.101236_bib143","article-title":"Changes in the foveal outer nuclear layer of central serous chorioretinopathy patients over the disease course and their response to photodynamic therapy","volume":"8","author":"Deng","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.preteyeres.2024.101236_bib144","first-page":"2976","article-title":"Heat shock protein hyperexpression on chorioretinal layers after transpupillary thermotherapy","volume":"42","author":"Desmettre","year":"2001","journal-title":"Investig. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib145","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.2147\/OPTH.S151933","article-title":"Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy","volume":"11","author":"Dhirani","year":"2017","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib146","series-title":"Text-book of Ophthalmology","author":"Duke-Elder","year":"1940"},{"key":"10.1016\/j.preteyeres.2024.101236_bib147","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ajo.2006.04.059","article-title":"Bilateral diffuse melanocytic proliferation associated with ovarian carcinoma and metastatic malignant amelanotic melanoma","volume":"142","author":"Duong","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib148","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/00006982-200512000-00006","article-title":"Acute central serous chorioretinopathy and fundus autofluorescence","volume":"25","author":"Eandi","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib149","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ophtha.2014.06.038","article-title":"Visual cycle suppression via patching in central serous chorioretinopathy","volume":"121","author":"Earl","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib150","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.survophthal.2009.05.003","article-title":"Uveal effusion syndrome","volume":"55","author":"Elagouz","year":"2010","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib151","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1007\/s00417-006-0368-5","article-title":"Selective retina therapy in patients with central serous chorioretinopathy","volume":"244","author":"Elsner","year":"2006","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2023.103896","article-title":"Hyperplasia of the retinal pigment epithelium secondary to subthreshold laser treatment in chronic central serous chorioretinopathy","volume":"44","author":"Enriquez-Fuentes","year":"2023","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.preteyeres.2024.101236_bib153","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3341\/kjo.2012.26.2.139","article-title":"Intravitreal bevacizumab for treatment of refractory central serous choroidoretinopathy","volume":"26","author":"Entezari","year":"2012","journal-title":"Korean J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib154","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3341\/kjo.2012.26.4.260","article-title":"Systemic factors associated with central serous chorioretinopathy in koreans","volume":"26","author":"Eom","year":"2012","journal-title":"Korean J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib155","first-page":"1160","article-title":"Ophthalmic manifestations of 107 cases with hemolysis, elevated liver enzymes and low platelet count syndrome","volume":"29","author":"Erbagci","year":"2008","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.preteyeres.2024.101236_bib156","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1097\/IAE.0000000000001773","article-title":"Indocyanine green angiography of pachychoroid pigment epitheliopathy","volume":"38","author":"Ersoz","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib157","article-title":"Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients","author":"Ersoz","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib158","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/jamaophthalmol.2022.0663","article-title":"Risk of ocular adverse events associated with use of phosphodiesterase 5 inhibitors in men in the us","volume":"140","author":"Etminan","year":"2022","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib159","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257763","article-title":"Choroidal features in flat irregular pigment epithelial detachment associated with chronic central serous chorioretinopathy: avascular versus vascularized","volume":"16","author":"Faghihi","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.preteyeres.2024.101236_bib160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4103\/jovr.jovr_139_16","article-title":"Visual and anatomical outcomes of spironolactone therapy in patients with chronic central serous chorioretinopathy","volume":"12","author":"Falavarjani","year":"2017","journal-title":"J. Ophthal. Vis. Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib161","article-title":"Hair dye-induced retinopathy mimicking mek-inhibitor retinopathy","author":"Faure","year":"2020","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib162","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/IAE.0000000000003686","article-title":"Increasing evidence for the safety of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy","volume":"43","author":"Feenstra","year":"2023","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib163","article-title":"Efficacy of half-dose photodynamic therapy versus high-density subthreshold micropulse laser for treating pigment epithelial detachments in chronic central serous chorioretinopathy","author":"Feenstra","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib164","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.oret.2022.04.023","article-title":"Spontaneous resolution of chronic central serous chorioretinopathy: \"Fuji sign\"","volume":"6","author":"Feenstra","year":"2022","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib165","article-title":"Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: spectra trial report No. 3","author":"Feenstra","year":"2022","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib166","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.oret.2022.04.014","article-title":"Crossover to half-dose photodynamic therapy or eplerenone in chronic central serous chorioretinopathy patients","volume":"6","author":"Feenstra","year":"2022","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib167","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/iovs.64.2.10","article-title":"Genetic variability of complement factor h has ethnicity-specific associations with choroidal thickness","volume":"64","author":"Fenner","year":"2023","journal-title":"Investig. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib168","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1097\/IAE.0000000000003876","article-title":"Two-year clinical outcomes after photodynamic acute exudative maculopathy in patients with chronic central serous chorioretinopathy","volume":"43","author":"Fernandez-Vigo","year":"2023","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib169","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10384-021-00870-4","article-title":"Assessment of the anterior scleral thickness in central serous chorioretinopathy patients by optical coherence tomography","volume":"65","author":"Fernandez-Vigo","year":"2021","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib170","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/IAE.0000000000003404","article-title":"Acute exudative maculopathy and bacillary layer detachment in patients with central serous chorioretinopathy after photodynamic therapy","volume":"42","author":"Fernandez-Vigo","year":"2022","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib171","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ophtha.2013.10.014","article-title":"En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy","volume":"121","author":"Ferrara","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib172","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/bjo.72.11.829","article-title":"Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy","volume":"72","author":"Ficker","year":"1988","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib173","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0002-9394(14)75205-5","article-title":"Central serous retinopathy in a 7-year-old girl","volume":"90","author":"Fine","year":"1980","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib174","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-1302-3_1","article-title":"An overview of helicobacter pylori infection","volume":"2283","author":"FitzGerald","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib175","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000324599","article-title":"Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy","volume":"46","author":"Fok","year":"2011","journal-title":"Ophthal. Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib176","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/IAE.0b013e3181f04a35","article-title":"Finasteride for chronic central serous chorioretinopathy","volume":"31","author":"Forooghian","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib177","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1177\/1120672120952648","article-title":"Eplerenone for treatment of chronic central serous chorioretinopathy","volume":"31","author":"Fraenkel","year":"2021","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib178","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000439188","article-title":"Selective retina therapy in acute and chronic-recurrent central serous chorioretinopathy","volume":"234","author":"Framme","year":"2015","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2024.101236_bib179","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1080\/02713680902964892","article-title":"Structural changes of the retina after conventional laser photocoagulation and selective retina treatment (srt) in spectral domain oct","volume":"34","author":"Framme","year":"2009","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib180","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/ceo.12905","article-title":"Hypertensive eye disease: a review","volume":"45","author":"Fraser-Bell","year":"2017","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib181","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/IAE.0b013e3181b7740f","article-title":"Central serous chorioretinopathy and phosphodiesterase-5 inhibitors: a case-control postmarketing surveillance study","volume":"30","author":"French","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib182","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/jamaophthalmol.2013.5030","article-title":"Increased fundus autofluorescence related to outer retinal disruption","volume":"131","author":"Freund","year":"2013","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib183","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/archopht.1996.01100130547007","article-title":"The expanding clinical spectrum of unilateral acute idiopathic maculopathy","volume":"114","author":"Freund","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib184","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/S0161-6420(97)30061-X","article-title":"The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser","volume":"104","author":"Friberg","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib185","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.preteyeres.2024.101236_bib186","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ophtha.2014.09.034","article-title":"One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy","volume":"122","author":"Fujita","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib187","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/IAE.0b013e3182680a66","article-title":"Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration","volume":"32","author":"Fung","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib188","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/ceo.13732","article-title":"Subretinal fluid and choroidal venous congestion secondary to a presumed dural cavernous sinus fistula","volume":"48","author":"Fuzzard","year":"2020","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib189","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s003470050310","article-title":"[central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects]","volume":"95","author":"Gackle","year":"1998","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.preteyeres.2024.101236_bib190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00417-012-2023-7","article-title":"Ranibizumab for serous macular detachment in branch retinal vein occlusions","volume":"251","author":"Gallego-Pinazo","year":"2013","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib191","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/bjo.81.11.962","article-title":"Endogenous cortisol profile in patients with central serous chorioretinopathy","volume":"81","author":"Garg","year":"1997","journal-title":"Br. J. Ophthalmol."},{"issue":"Suppl. l","key":"10.1016\/j.preteyeres.2024.101236_bib192","first-page":"1","article-title":"Pathogenesis of disciform detachment of the neuroepithelium","volume":"63","author":"Gass","year":"1967","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib193","first-page":"354","article-title":"Acute exudative polymorphous vitelliform maculopathy","volume":"86","author":"Gass","year":"1988","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.preteyeres.2024.101236_bib194","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archopht.1990.01070060075053","article-title":"Bilateral diffuse uveal melanocytic proliferation in patients with occult carcinoma","volume":"108","author":"Gass","year":"1990","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib195","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0161-6420(82)34685-0","article-title":"Idiopathic serous detachment of the choroid, ciliary body, and retina (uveal effusion syndrome)","volume":"89","author":"Gass","year":"1982","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib196","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00417-017-3783-x","article-title":"Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser","volume":"255","author":"Gawecki","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib197","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8091398","article-title":"Transfoveal micropulse laser treatment of central serous chorioretinopathy within six months of disease onset","volume":"8","author":"Gaw\u0119cki","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2024.101236_bib198","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00417-019-04486-w","article-title":"Corticosteroids usage and central serous chorioretinopathy: a meta-analysis","volume":"258","author":"Ge","year":"2020","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib199","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1176\/ajp.144.1.46","article-title":"Loss of vision due to central serous chorioretinopathy following psychological stress","volume":"144","author":"Gelber","year":"1987","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.preteyeres.2024.101236_bib200","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/eye.2010.130","article-title":"Central serous chorioretinopathy: an update on pathogenesis and treatment","volume":"24","author":"Gemenetzi","year":"2010","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib201","doi-asserted-by":"crossref","first-page":"e776","DOI":"10.1111\/aos.13665","article-title":"Correlation between morphological characteristics in spectral-domain-optical coherence tomography, different functional tests and a patient's subjective handicap in acute central serous chorioretinopathy","volume":"96","author":"Gerendas","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib202","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/IAE.0000000000001303","article-title":"Mineralocorticoid receptor antagonist treatment in bilateral chronic central serous chorioretinopathy: a comparative study of exudative and nonexudative fellow eyes","volume":"37","author":"Gergely","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib203","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/bjo.68.11.815","article-title":"Long-term follow-up of central serous chorioretinopathy","volume":"68","author":"Gilbert","year":"1984","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib204","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/OPTH.S16014","article-title":"Large-spot subthreshold transpupillary thermotherapy for chronic serous macular detachment","volume":"5","author":"Giudice","year":"2011","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib205","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.4103\/ijo.IJO_3401_20","article-title":"Multifocal electroretinography-assisted anatomical and functional evaluation of subthreshold green laser in acute central serous chorioretinopathy","volume":"69","author":"Goel","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib206","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1755-3768.2008.01467.x","article-title":"Ketoconazole in the treatment of central serous chorioretinopathy: a pilot study","volume":"88","author":"Golshahi","year":"2010","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib207","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ajo.2012.05.001","article-title":"Reduced-fluence photodynamic therapy for subfoveal serous pigment epithelial detachment with choroidal vascular hyperpermeability","volume":"154","author":"Goto","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib208","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"New England J. Med."},{"key":"10.1016\/j.preteyeres.2024.101236_bib209","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/eye.2015.104","article-title":"Therapeutic benefit of melatonin in refractory central serous chorioretinopathy","volume":"29","author":"Gramajo","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib210","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000510670","article-title":"Desferrioxamine-related pseudo-vitelliform dystrophy and the effect of anti-vascular endothelial growth factor","volume":"12","author":"Grinton","year":"2021","journal-title":"Case Rep. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib211","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1136\/bjo.2005.072546","article-title":"Hypertensive retinopathy revisited: some answers, more questions","volume":"89","author":"Grosso","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib212","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","volume":"117","author":"Group","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.39.1.1","article-title":"Cytochrome p-450 3a4: regulation and role in drug metabolism","volume":"39","author":"Guengerich","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib214","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/IAE.0000000000002791","article-title":"Clinical features of flat irregular pigment epithelial detachment associated with choroidal neovascularization in chronic central serous chorioretinopathy","volume":"41","author":"Guo","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib215","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1038\/s41433-020-01345-5","article-title":"Octa evaluation of treatment-na\u00efve flat irregular ped (fiped)-associated cnv in chronic central serous chorioretinopathy before and after half-dose pdt","volume":"35","author":"Guo","year":"2021","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib216","series-title":"Micropulse Diode Laser Photocoagulation for Central Serous Chorio-Retinopathy","author":"Gupta","year":"2009"},{"key":"10.1016\/j.preteyeres.2024.101236_bib217","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/IAE.0b013e3181cd4998","article-title":"Diagnostic and therapeutic challenges","volume":"30","author":"Gupta","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib218","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archopht.1994.01090200063023","article-title":"Digital indocyanine green videoangiography of central serous chorioretinopathy","volume":"112","author":"Guyer","year":"1994","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib219","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181479","article-title":"Long-term prognostic factors of chronic central serous chorioretinopathy after half-dose photodynamic therapy: a 3-year follow-up study","volume":"12","author":"Haga","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.preteyeres.2024.101236_bib220","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ajo.2021.10.021","article-title":"The diagnostic accuracy of double-layer sign in detection of macular neovascularization secondary to central serous chorioretinopathy","volume":"236","author":"Hagag","year":"2021","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib221","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00417-012-2139-9","article-title":"The effect of photodynamic therapy on macular sensitivity in eyes with acute central serous chorioretinopathy","volume":"251","author":"Hagen","year":"2013","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib222","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0161-6420(97)30082-7","article-title":"Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids","volume":"104","author":"Haimovici","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib223","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ophtha.2003.09.024","article-title":"Risk factors for central serous chorioretinopathy: a case-control study","volume":"111","author":"Haimovici","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib224","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0161-6420(02)01975-9","article-title":"Endocrine abnormalities in patients with central serous chorioretinopathy","volume":"110","author":"Haimovici","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib225","article-title":"Fundus autofluorescence patterns in central serous chorioretinopathy","author":"Han","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib226","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/IAE.0000000000002580","article-title":"Fundus autofluorescence patterns in central serous chorioretinopathy","volume":"40","author":"Han","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib227","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1167\/iovs.13-12854","article-title":"Changes in choroidal thickness after systemic administration of high-dose corticosteroids: a pilot study","volume":"55","author":"Han","year":"2014","journal-title":"Investig. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib228","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1111\/aos.12262","article-title":"Retinal degeneration and persistent serous detachment in the absence of active choroidal neovascularization in pseudoxanthoma elasticum","volume":"92","author":"Hansen","year":"2014","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib229","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/IAE.0b013e31826710a0","article-title":"Early changes in foveal thickness in eyes with central serous chorioretinopathy","volume":"33","author":"Hata","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib230","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00225936","article-title":"Indocyanine green angiography of central serous chorioretinopathy","volume":"9","author":"Hayashi","year":"1986","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib231","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2020.101955","article-title":"Comparison between the outcomes of fluorescein angiography-guided and indocyanine green angiography-guided half-time photodynamic therapy for central serous chorioretinopathy","volume":"31","author":"Hayashida","year":"2020","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.preteyeres.2024.101236_bib232","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00417-014-2780-6","article-title":"Spironolactone in the treatment of central serous chorioretinopathy - a case series","volume":"252","author":"Herold","year":"2014","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib233","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00417-016-3436-5","article-title":"Long-term results and recurrence rates after spironolactone treatment in non-resolving central serous chorio-retinopathy (cscr)","volume":"255","author":"Herold","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib234","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/0974-620X.192288","article-title":"Flat choroidal melanoma masquerading as central serous chorioretinopathy","volume":"9","author":"Higgins","year":"2016","journal-title":"Oman J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib235","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.oret.2017.05.013","article-title":"Dilatation of asymmetric vortex vein in central serous chorioretinopathy","volume":"2","author":"Hiroe","year":"2018","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib236","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/bjophthalmol-2020-316076","article-title":"Analysis of choriocapillaris perfusion and choroidal layer changes in patients with chronic central serous chorioretinopathy randomised to micropulse laser or photodynamic therapy","volume":"105","author":"Ho","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib237","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11154437","article-title":"Pachychoroid spectrum diseases in patients with cushing's syndrome: a systematic review with meta-analyses","volume":"11","author":"Holtz","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2024.101236_bib238","doi-asserted-by":"crossref","first-page":"9105","DOI":"10.1038\/s41598-022-13208-y","article-title":"Early anatomical changes and association with photodynamic therapy induced acute exudative maculopathy in patients with macular diseases","volume":"12","author":"Honda","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib239","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s42003-019-0712-z","article-title":"Genome-wide association analyses identify two susceptibility loci for pachychoroid disease central serous chorioretinopathy","volume":"2","author":"Hosoda","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib240","doi-asserted-by":"crossref","DOI":"10.1016\/j.oret.2019.05.025","article-title":"Predictive genes for the prognosis of central serous chorioretinopathy","author":"Hosoda","year":"2019","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib241","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1073\/pnas.1802212115","article-title":"Cfh and vipr2 as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy","volume":"115","author":"Hosoda","year":"2018","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2024.101236_bib242","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/IAE.0000000000002795","article-title":"Optical coherence tomography angiography-guided photodynamic therapy for acute central serous chorioretinopathy","volume":"41","author":"Hu","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib243","first-page":"278","article-title":"Clinical research on one-third dose verteporfin photodynamic therapy in the treatment of chronic central serous chorioretinopathy","volume":"22","author":"Hua","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib244","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/ICB.0b013e3181f7f7ee","article-title":"Acute idiopathic maculopathy with coxsackievirus infection","volume":"6","author":"Hughes","year":"2012","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib245","series-title":"Eplerenone, Statpearls, Treasure Island (FL)","author":"Hughes","year":"2022"},{"key":"10.1016\/j.preteyeres.2024.101236_bib246","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00417-005-0175-4","article-title":"Transpupillary thermotherapy for chronic central serous chorioretinopathy","volume":"244","author":"Hussain","year":"2006","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib247","article-title":"Photodynamic therapy for symptomatic subfoveal retinal pigment epithelial detachment in central serous chorioretinopathy: outcomes and prognostic factors","author":"Hwang","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib248","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1097\/IAE.0000000000003067","article-title":"Choroidal neovascularization secondary to photodynamic therapy for central serous chorioretinopathy: incidence, risk factors, and clinical outcomes","volume":"41","author":"Hwang","year":"2021","journal-title":"Retina"},{"issue":"1\u20137","key":"10.1016\/j.preteyeres.2024.101236_bib249","first-page":"137","article-title":"Cystoid macular degeneration in chronic central serous chorioretinopathy","volume":"23","author":"Iida","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib250","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0002-9394(98)00378-X","article-title":"Plasminogen activator inhibitor 1 in central serous chorioretinopathy","volume":"127","author":"Iijima","year":"1999","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib251","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1097\/IAE.0000000000001489","article-title":"Overview of the complications of high myopia","volume":"37","author":"Ikuno","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib252","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1167\/iovs.09-4383","article-title":"Choroidal thickness in healthy Japanese subjects","volume":"51","author":"Ikuno","year":"2010","journal-title":"Investig. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib253","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/IAE.0b013e3181be0a83","article-title":"Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy","volume":"29","author":"Imamura","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib254","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ophtha.2010.08.017","article-title":"Fundus autofluorescence and visual acuity in central serous chorioretinopathy","volume":"118","author":"Imamura","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib255","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.oret.2020.07.011","article-title":"Scleral thickness in central serous chorioretinopathy","volume":"5","author":"Imanaga","year":"2021","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib256","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ajo.2021.09.009","article-title":"Clinical factors related to loculation of fluid in central serous chorioretinopathy","volume":"235","author":"Imanaga","year":"2022","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib257","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/iovs.64.1.16","article-title":"Relationship between scleral thickness and choroidal structure in central serous chorioretinopathy","volume":"64","author":"Imanaga","year":"2023","journal-title":"Investig. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib258","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000314709","article-title":"Results of one-year follow-up examinations after intravitreal bevacizumab administration for chronic central serous chorioretinopathy","volume":"225","author":"Inoue","year":"2011","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2024.101236_bib259","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ajo.2009.10.011","article-title":"Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy","volume":"149","author":"Inoue","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib260","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ajo.2020.04.022","article-title":"Choroidal anatomic alterations after photodynamic therapy for chronic central serous chorioretinopathy: a multicenter study","volume":"217","author":"Iovino","year":"2020","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib261","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41433-021-01515-z","article-title":"Photodynamic therapy as a treatment option for peripapillary pachychoroid syndrome: a pilot study","volume":"36","author":"Iovino","year":"2022","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib262","article-title":"Eplerenone treatment in chronic central serous chorioretinopathy","volume":"13","author":"Iqbal","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.preteyeres.2024.101236_bib263","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.18240\/ijo.2020.09.11","article-title":"Efficacy of the subthreshold micropulse yellow wavelength laser photostimulation in the treatment of chronic central serous chorioretinopathy","volume":"13","author":"I\u015f\u0131k","year":"2020","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib264","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/02713683.2021.1962360","article-title":"Determination of micropulse modes with targeted damage to the retinal pigment epithelium using computer modeling for the development of selective individual micropulse retinal therapy","volume":"47","author":"Ivanova","year":"2022","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib265","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/bjophthalmol-2016-308921","article-title":"Structural analyses of choroid after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy","volume":"101","author":"Izumi","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib266","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ajo.2014.06.001","article-title":"Pathogenesis and treatment of maculopathy associated with cavitary optic disc anomalies","volume":"158","author":"Jain","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib267","article-title":"The effect of selective retina therapy for bevacizumab-resistant chronic central serous chorioretinopathy","author":"Jeon","year":"2021","journal-title":"Ophthalmologica."},{"key":"10.1016\/j.preteyeres.2024.101236_bib268","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11096-017-0460-4","article-title":"Clinical efficacy of anti-vegf medications for central serous chorioretinopathy: a meta-analysis","volume":"39","author":"Ji","year":"2017","journal-title":"Int. J. Clin. Pharm."},{"key":"10.1016\/j.preteyeres.2024.101236_bib269","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9450297","article-title":"Poor sleep quality is the risk factor for central serous chorioretinopathy","volume":"2018","author":"Ji","year":"2018","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib270","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00160764","article-title":"Transpupillary thermotherapy (ttt) by infrared irradiation of choroidal melanoma","volume":"82","author":"Journee-de Korver","year":"1992","journal-title":"Docum. Ophthalmol. Adv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib271","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1038\/s41598-019-38504-y","article-title":"Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy","volume":"9","author":"Jung","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib272","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.18240\/ijo.2019.12.08","article-title":"Chorioretinal response to intravitreal aflibercept injection in acute central serous chorioretinopathy","volume":"12","author":"Jung","year":"2019","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib273","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0284979","article-title":"Two-year outcome of half-time photodynamic therapy for chronic central serous chorioretinopathy with and without choroidal neovascularization","volume":"18","author":"Kamimura","year":"2023","journal-title":"PloS One"},{"key":"10.1016\/j.preteyeres.2024.101236_bib274","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238725","article-title":"Long-term treatment response after intravitreal bevacizumab injections for patients with central serous chorioretinopathy","volume":"15","author":"Kang","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.preteyeres.2024.101236_bib275","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002524","article-title":"Selective retina therapy in patients with chronic central serous chorioretinopathy: a pilot study","volume":"95","author":"Kang","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.preteyeres.2024.101236_bib276","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1055\/s-2008-1034901","article-title":"[serous central chorioretinopathy and endogenous hypercortisolemia]","volume":"212","author":"Kapetanios","year":"1998","journal-title":"Klin. Monatsblatt. Augenheilk."},{"key":"10.1016\/j.preteyeres.2024.101236_bib277","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000444058","article-title":"Mineralocorticoid antagonists in the treatment of central serous chorioretinopathy: a comparative analysis","volume":"56","author":"Kapoor","year":"2016","journal-title":"Ophthal. Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib278","first-page":"1","article-title":"The effect of eplerenone in chronic central serous chorioretinopathy refractory to photodynamic therapy","author":"Karagiannis","year":"2019","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib279","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/eye.2013.24","article-title":"Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes","volume":"27","author":"Karakus","year":"2013","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib280","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/1756-0500-6-530","article-title":"An atypical case of choroidal neovascularization associated with pseudoxanthoma elasticum treated with intravitreal bevacizumab: a case report","volume":"6","author":"Karampelas","year":"2013","journal-title":"BMC Res. Notes"},{"issue":"2","key":"10.1016\/j.preteyeres.2024.101236_bib281","doi-asserted-by":"crossref","first-page":"123","DOI":"10.37845\/ret.vit.2021.30.22","article-title":"Comparison of visual and anatomical outcomes of half fluence - full dose and half dose - full fluence photodynamic therapy in eyes with chronic central serous chorioretinopathy","volume":"30","author":"Karasu","year":"2021","journal-title":"Retina-Vitreus"},{"key":"10.1016\/j.preteyeres.2024.101236_bib282","doi-asserted-by":"crossref","first-page":"724","DOI":"10.5114\/aoms.2020.92694","article-title":"Quality of life of patients with central serous chorioretinopathy - a major cause of vision threat among middle-aged individuals","volume":"17","author":"Karska-Basta","year":"2021","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib283","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/OPTH.S28239","article-title":"Transpupillary thermotherapy for atypical central serous chorioretinopathy","volume":"6","author":"Kawamura","year":"2012","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib284","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100865","article-title":"Central serous chorioretinopathy: an update on risk factors, pathophysiology and imaging modalities","volume":"79","author":"Kaye","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib285","first-page":"1158","article-title":"Effect of half adult dose of oral rifampicin (300mg) in patients with idiopathic central serous chorioretinopathy","volume":"32","author":"Khan","year":"2016","journal-title":"Pak. J. Med. Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib286","article-title":"Incidence of central serous chorioretinopathy (2011-2018): a nationwide population-based cohort study of Japan","author":"Kido","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib287","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3341\/kjo.2015.29.3.160","article-title":"The association between choroidal thickness variations and response to intravitreal bevacizumab in central serous chorioretinopathy","volume":"29","author":"Kim","year":"2015","journal-title":"Korean J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib288","article-title":"Comparison of visual\/anatomical outcomes and recurrence rate between oral spironolactone and photodynamic therapy for nonresolving central serous chorioretinopathy","author":"Kim","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib289","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1755-3768.2011.02305.x","article-title":"Measurement of choroidal perfusion and thickness following systemic sildenafil (viagra(\u00ae))","volume":"91","author":"Kim","year":"2013","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib290","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/eye.2015.58","article-title":"Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients","volume":"29","author":"Kim","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib291","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/eye.2015.215","article-title":"Comparison of subfoveal choroidal thickness in healthy pregnancy and pre-eclampsia","volume":"30","author":"Kim","year":"2016","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib292","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4258763","article-title":"Mineralocorticoid receptor antagonist treatment for steroid-induced central serous chorioretinopathy patients with continuous systemic steroid treatment","author":"Kim","year":"2018","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib293","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s00417-015-2965-7","article-title":"Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy","volume":"253","author":"Kim","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib294","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ajo.2013.10.013","article-title":"Half-dose photodynamic therapy targeting the leakage point on the fluorescein angiography in acute central serous chorioretinopathy: a pilot study","volume":"157","author":"Kim","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib295","article-title":"Factors predicting response to selective retina therapy in patients with chronic central serous chorioretinopathy","volume":"11","author":"Kim","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2024.101236_bib296","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000345495","article-title":"Intravitreal ranibizumab for acute central serous chorioretinopathy","volume":"229","author":"Kim","year":"2013","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2024.101236_bib297","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1038\/s41598-022-08550-0","article-title":"Factors related to the location of pigment epithelial detachment in central serous chorioretinopathy","volume":"12","author":"Kim","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib298","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41433-018-0309-7","article-title":"Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years","volume":"33","author":"Kim","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib299","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6027871","article-title":"Selective retina therapy with real-time feedback-controlled dosimetry for treating acute idiopathic central serous chorioretinopathy in Korean patients","author":"Kim","year":"2018","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib300","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajo.2015.04.011","article-title":"Choroidal thickness changes after photodynamic therapy and recurrence of chronic central serous chorioretinopathy","volume":"160","author":"Kim","year":"2015","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib301","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s00417-014-2926-6","article-title":"Comparison of visual and anatomical outcomes of half-fluence and half-dose photodynamic therapy in eyes with chronic central serous chorioretinopathy","volume":"253","author":"Kim","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib302","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3341\/kjo.2017.0144","article-title":"Association of central serous chorioretinopathy with psychosocial factors is dependent on its phase and subtype","volume":"32","author":"Kim","year":"2018","journal-title":"Korean J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib303","doi-asserted-by":"crossref","DOI":"10.3390\/genes13010055","article-title":"Associations of single-nucleotide polymorphisms in slovenian patients with acute central serous chorioretinopathy","volume":"13","author":"Kiraly","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.preteyeres.2024.101236_bib304","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206646","article-title":"Geographic filling delay of the choriocapillaris in the region of dilated asymmetric vortex veins in central serous chorioretinopathy","volume":"13","author":"Kishi","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.preteyeres.2024.101236_bib305","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ophtha.2007.02.032","article-title":"The incidence of central serous chorioretinopathy in olmsted county, Minnesota, 1980-2002","volume":"115","author":"Kitzmann","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib306","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bjo.2009.178327","article-title":"Selective retina therapy for acute central serous chorioretinopathy","volume":"95","author":"Klatt","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib307","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archopht.1974.03900060257001","article-title":"Experience with nontreatment of central serous choroidopathy","volume":"91","author":"Klein","year":"1974","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib308","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/aos.13481","article-title":"Bilateral diffuse uveal melanocytic proliferation: case report and literature review","volume":"95","author":"Klemp","year":"2017","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib309","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9394(99)00273-1","article-title":"Indocyanine green angiographic features of choroidal rupture and choroidal vascular injury after contusion ocular injury","volume":"129","author":"Kohno","year":"2000","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib310","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ophtha.2015.10.039","article-title":"Subfoveal choroidal thickness during aflibercept therapy for neovascular age-related macular degeneration: twelve-month results","volume":"123","author":"Koizumi","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib311","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/eye.2011.282","article-title":"Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy","volume":"26","author":"Koss","year":"2012","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib312","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ophtha.2010.10.007","article-title":"Clinical evaluation and treatment accuracy in diabetic macular edema using navigated laser photocoagulator navilas","volume":"118","author":"Kozak","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib313","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3928\/23258160-20150909-08","article-title":"Randomized clinical trial to compare micropulse photocoagulation versus half-dose verteporfin photodynamic therapy in the treatment of central serous chorioretinopathy","volume":"46","author":"Kretz","year":"2015","journal-title":"Ophthal. Surg., Lasers Imag. Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib314","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/IAE.0000000000003275","article-title":"Peripapillary pachychoroid syndrome: new insights","volume":"42","author":"Kumar","year":"2022","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib315","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1097\/IAE.0b013e31825dd281","article-title":"Low-dose methotrexate for the treatment of chronic central serous chorioretinopathy: a retrospective analysis","volume":"32","author":"Kurup","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib316","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1038\/s41598-021-88372-8","article-title":"Factors affecting resolution of subretinal fluid after selective retina therapy for central serous chorioretinopathy","volume":"11","author":"Kyo","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib317","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1755-3768.1994.tb07175.x","article-title":"Diffuse chronic retinal pigment epitheliopathy and exudative retinal detachment","volume":"72","author":"Laatikainen","year":"1994","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.preteyeres.2024.101236_bib318","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1088\/0031-9155\/27\/11\/002","article-title":"A microwave heating technique for the hyperthermic treatment of tumours in the eye, especially retinoblastoma","volume":"27","author":"Lagendijk","year":"1982","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib319","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/08039488.2015.1041156","article-title":"Psychological factors associated with acute and chronic central serous chorioretinopathy","volume":"70","author":"Lahousen","year":"2016","journal-title":"Nordic J. Psychiatr."},{"key":"10.1016\/j.preteyeres.2024.101236_bib320","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ajo.2016.07.026","article-title":"A multicenter study on the long-term outcomes of half-dose photodynamic therapy in chronic central serous chorioretinopathy","volume":"170","author":"Lai","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib321","first-page":"T8","article-title":"Long-term outcome of half-dose verteporfin photodynamic therapy for the treatment of central serous chorioretinopathy (an american ophthalmological society thesis)","volume":"113","author":"Lai","year":"2015","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.preteyeres.2024.101236_bib322","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/IAE.0000000000001744","article-title":"Efficacy and safety of ranibizumab for the treatment of choroidal neovascularization due to uncommon cause: twelve-month results of the minerva study","volume":"38","author":"Lai","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib323","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1177\/112067210801800613","article-title":"Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study","volume":"18","author":"Lanzetta","year":"2008","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib324","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/IAE.0000000000000340","article-title":"Nondamaging photothermal therapy for the retina: initial clinical experience with chronic central serous retinopathy","volume":"35","author":"Lavinsky","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib325","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bjo.63.10.674","article-title":"Argon laser photocoagulation in the treatment of central serous retinopathy","volume":"63","author":"Leaver","year":"1979","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib326","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1097\/IAE.0000000000000929","article-title":"Baseline spectral domain optical coherence tomographic hyperreflective foci as a predictor of visual outcome and recurrence for central serous chorioretinopathy","volume":"36","author":"Lee","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib327","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1111\/j.1755-3768.2009.01835.x","article-title":"Intravitreal bevacizumab versus the conventional protocol of photodynamic therapy for treatment of chronic central serous chorioretinopathy","volume":"89","author":"Lee","year":"2011","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib328","article-title":"The effect of selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy: a randomized, open-label, controlled clinical trial","volume":"10","author":"Lee","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2024.101236_bib329","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/eye.2016.113","article-title":"Fundus autofluorescence imaging patterns in central serous chorioretinopathy according to chronicity","volume":"30","author":"Lee","year":"2016","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib330","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1038\/s41598-021-85229-y","article-title":"A pilot study of scleral thickness in central serous chorioretinopathy using anterior segment optical coherence tomography","volume":"11","author":"Lee","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib331","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/IAE.0000000000000287","article-title":"Pachychoroid: an inherited condition?","volume":"35","author":"Lehmann","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib332","article-title":"Type one macular neovascularization in central serous chorioretinopathy: short-term response to anti-vascular endothelial growth factor therapy","author":"Lejoyeux","year":"2021","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib333","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0161-6420(89)32810-7","article-title":"Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography","volume":"96","author":"Levine","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib334","doi-asserted-by":"crossref","DOI":"10.1007\/s00417-021-05531-3","article-title":"Risk factors of persistent subretinal fluid after half-dose photodynamic therapy for treatment-na\u00efve central serous chorioretinopathy","author":"Li","year":"2022","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib335","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41433-020-0858-4","article-title":"Comparison of the outcomes of photodynamic therapy for central serous chorioretinopathy with or without subfoveal fibrin","volume":"35","author":"Liang","year":"2021","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib336","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.9.13.6","article-title":"Efficacy of topical carbonic anhydrase inhibitors in reducing duration of chronic central serous chorioretinopathy","volume":"9","author":"Liew","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib337","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/02656739009140948","article-title":"Localized current field hyperthermia: effect on normal ocular tissue","volume":"6","author":"Liggett","year":"1990","journal-title":"Int. J. Hyperther."},{"key":"10.1016\/j.preteyeres.2024.101236_bib338","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ophtha.2013.11.040","article-title":"Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy","volume":"121","author":"Lim","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib339","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00417-010-1581-9","article-title":"The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy","volume":"249","author":"Lim","year":"2011","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib340","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/IAE.0b013e3181bcf0b4","article-title":"Intravitreal bevacizumab injection for central serous chorioretinopathy","volume":"30","author":"Lim","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib341","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1136\/bjo.2009.176800","article-title":"Choroidal macrovessel","volume":"95","author":"Lima","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib342","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s004179900110","article-title":"Familial central serous choroidopathy","volume":"238","author":"Lin","year":"2000","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib343","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/IAE.0000000000000837","article-title":"Risk factors for central serous chorioretinopathy: a systematic review and meta-analysis","volume":"36","author":"Liu","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib344","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1089\/jop.2013.0169","article-title":"Half-dose verteporfin combined with half-fluence photodynamic therapy for chronic central serous chorioretinopathy","volume":"30","author":"Liu","year":"2014","journal-title":"J. Ocul. Pharmacol. Therap."},{"key":"10.1016\/j.preteyeres.2024.101236_bib345","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ajo.2016.04.001","article-title":"Half-dose versus half-time photodynamic therapy for central serous chorioretinopathy","volume":"167","author":"Liu","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib346","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/bjophthalmol-2019-315318","article-title":"Optical coherence tomography angiography of flat irregular pigment epithelial detachments in central serous chorioretinopathy","volume":"105","author":"Liu","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib347","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00006982-200202000-00004","article-title":"Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy","volume":"22","author":"Loo","year":"2002","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib348","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(19)32981-2","article-title":"Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (vici): a randomised, double-blind, placebo-controlled trial","volume":"395","author":"Lotery","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2024.101236_bib349","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.12669\/pjms.35.6.990","article-title":"Effect of altering the regime of oral rifampicin therapy in the treatment of persistent central serous chorioretinopathy","volume":"35","author":"Loya","year":"2019","journal-title":"Pak. J. Med. Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib350","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/eye.2015.208","article-title":"Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: a systematic review and meta-analysis","volume":"30","author":"Lu","year":"2016","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib351","first-page":"608","article-title":"Idiopathic central serous retinopathy in China: a report of 600 cases (624 eyes) treated by acupuncture","volume":"18","author":"Lu","year":"1987","journal-title":"Ophthal. Surg."},{"key":"10.1016\/j.preteyeres.2024.101236_bib352","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1097\/IAE.0000000000001005","article-title":"Low-intensity\/high-density subthreshold diode micropulse laser for central serous chorioretinopathy","volume":"36","author":"Luttrull","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib353","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/IAE.0000000000000285","article-title":"Low-intensity\/high-density subthreshold micropulse diode laser for chronic central serous chorioretinopathy","volume":"35","author":"Malik","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib354","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/112067210501500219","article-title":"Bilateral serous macular detachment as a presenting feature of acute lymphoblastic leukemia","volume":"15","author":"Malik","year":"2005","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib355","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/ICB.0000000000000356","article-title":"Incidence of acute exudative maculopathy after reduced-fluence photodynamic therapy","volume":"11","author":"Mammo","year":"2017","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib356","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1177\/1120672121991053","article-title":"Long-term outcomes of half-fluence photodynamic therapy and eplerenone in chronic central serous chorioretinopathy: a comparative study","volume":"31","author":"Manayath","year":"2021","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib357","first-page":"266","article-title":"Is myopia a protective factor against central serous chorioretinopathy?","volume":"9","author":"Manayath","year":"2016","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib358","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3928\/23258160-20170329-08","article-title":"Low fluence photodynamic therapy versus graded subthreshold transpupillary thermotherapy for chronic central serous chorioretinopathy: results from a prospective study","volume":"48","author":"Manayath","year":"2017","journal-title":"Ophthal. Surg., Lasers Imag. Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib359","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3928\/15428877-20120618-06","article-title":"Graded subthreshold transpupillary thermotherapy for chronic central serous chorioretinopathy","volume":"43","author":"Manayath","year":"2012","journal-title":"Ophthal. Surg., Lasers Imag."},{"key":"10.1016\/j.preteyeres.2024.101236_bib360","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/IAE.0000000000002343","article-title":"Photodynamic therapy-induced acute exudative maculopathy: incidence, clinical features, and long-term outcomes","volume":"40","author":"Manayath","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib361","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1136\/bjophthalmol-2018-313576","article-title":"Optical coherence tomography angiography findings in fellow eyes of choroidal neovascularisation associated with central serous chorioretinopathy","volume":"105","author":"Mandadi","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib362","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7409426","article-title":"The efficacy of intravitreal conbercept for chronic central serous chorioretinopathy","volume":"2019","author":"Mao","year":"2019","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib363","doi-asserted-by":"crossref","first-page":"719","DOI":"10.18240\/ijo.2021.05.12","article-title":"Comprehensive evaluation of intravitreal conbercept versus half-dose photodynamic therapy for chronic central serous chorioretinopathy","volume":"14","author":"Mao","year":"2021","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib364","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1097\/IAE.0b013e31822bf6b1","article-title":"One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy","volume":"31","author":"Maruko","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib365","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.ophtha.2010.01.023","article-title":"Subfoveal choroidal thickness after treatment of central serous chorioretinopathy","volume":"117","author":"Maruko","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib366","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184112","article-title":"Subthreshold 577 nm micropulse laser treatment for central serous chorioretinopathy","volume":"12","author":"Maruko","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.preteyeres.2024.101236_bib367","article-title":"Risk factors for recurrences of central serous chorioretinopathy","author":"Matet","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib368","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/IAE.0000000000001729","article-title":"Risk factors for recurrences of central serous chorioretinopathy","volume":"38","author":"Matet","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib369","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0377-1237(09)80092-0","article-title":"Role of transpupillary thermotherapy in central serous chorio-retinopathy","volume":"65","author":"Mathur","year":"2009","journal-title":"Med. J., Armed Forces India"},{"key":"10.1016\/j.preteyeres.2024.101236_bib370","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00006982-199808000-00002","article-title":"Two types of initial ocular manifestations in intraocular-central nervous system lymphoma","volume":"18","author":"Matsuo","year":"1998","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib371","first-page":"605","article-title":"Macular diseases: clinical manifestations. Transactions - American academy of ophthalmology and otolaryngology","volume":"69","author":"Maumenee","year":"1965","journal-title":"Am. Acad. Ophthalmol. Otolaryngol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib372","first-page":"801","article-title":"Pilot study of oral administration of a curcumin-phospholipid formulation for treatment of central serous chorioretinopathy","volume":"6","author":"Mazzolani","year":"2012","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib373","first-page":"939","article-title":"Oral administration of a curcumin-phospholipid delivery system for the treatment of central serous chorioretinopathy: a 12-month follow-up study","volume":"7","author":"Mazzolani","year":"2013","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib374","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/S0161-6420(99)90543-2","article-title":"Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients","volume":"106","author":"McCluskey","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib375","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1471-4892(01)00022-4","article-title":"Recent studies with eplerenone, a novel selective aldosterone receptor antagonist","volume":"1","author":"McMahon","year":"2001","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib376","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.preteyeres.2017.12.002","article-title":"Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors","volume":"65","author":"Mehta","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib377","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/bjophthalmol-2016-309247","article-title":"Preferred practice pattern in central serous chorioretinopathy","volume":"101","author":"Mehta","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib378","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/IAE.0b013e318050ca69","article-title":"Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy","volume":"27","author":"Meyerle","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib379","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archopht.1989.01070020598048","article-title":"Ferromagnetic hyperthermia and iodine 125 brachytherapy in the treatment of choroidal melanoma in a rabbit model","volume":"107","author":"Mieler","year":"1989","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib380","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.ophtha.2013.11.020","article-title":"Common variants in the complement factor h gene confer genetic susceptibility to central serous chorioretinopathy","volume":"121","author":"Miki","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib381","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1167\/iovs.18-25497","article-title":"Genome-wide association study to identify a new susceptibility locus for central serous chorioretinopathy in the Japanese population","volume":"59","author":"Miki","year":"2018","journal-title":"Investig. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib382","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/archopht.1993.01090060145039","article-title":"Photodynamic therapy of subretinal neovascularization in the monkey eye","volume":"111","author":"Miller","year":"1993","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib383","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0161-6420(91)32079-7","article-title":"Phthalocyanine photodynamic therapy of experimental iris neovascularization","volume":"98","author":"Miller","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib384","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1001\/archopht.1995.01100060136048","article-title":"Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin","volume":"113","author":"Miller","year":"1995","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib385","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13023-016-0429-8","article-title":"Birdshot chorioretinopathy: current knowledge and new concepts in pathophysiology, diagnosis, monitoring and treatment","volume":"11","author":"Minos","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.preteyeres.2024.101236_bib386","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1177\/1120672120915168","article-title":"A randomized clinical trial comparing prompt photodynamic therapy with 3 months observation in patients with acute central serous chorioretinopathy with central macular leakage","volume":"31","author":"Missotten","year":"2021","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib387","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00417-006-0277-7","article-title":"Three-dimensional optical coherence tomographic findings in central serous chorioretinopathy","volume":"244","author":"Mitarai","year":"2006","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib388","first-page":"355","article-title":"A case of ipilimumab-induced unusual serous retinal detachment in bilateral eyes","volume":"12","author":"Miyakubo","year":"2019","journal-title":"Int. Med. Case Rep. J."},{"key":"10.1016\/j.preteyeres.2024.101236_bib389","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40942-019-0190-y","article-title":"Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study","volume":"5","author":"Moein","year":"2019","journal-title":"Int. J. Retina Vitreous"},{"key":"10.1016\/j.preteyeres.2024.101236_bib390","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2147\/OPTH.S242926","article-title":"Risk of recurrence and transition to chronic disease in acute central serous chorioretinopathy","volume":"14","author":"Mohabati","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib391","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1097\/IAE.0000000000002683","article-title":"Clinical characteristics and outcome of posterior cystoid macular degeneration in chronic central serous chorioretinopathy","volume":"40","author":"Mohabati","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib392","article-title":"Genetic risk factors in acute central serous chorioretinopathy","author":"Mohabati","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib393","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1097\/IAE.0000000000002682","article-title":"Genetic risk factors in severe, nonsevere and acute phenotypes of central serous chorioretinopathy","volume":"40","author":"Mohabati","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib394","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.2147\/OPTH.S174573","article-title":"Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy","volume":"12","author":"Mohabati","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib395","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2147\/OPTH.S160956","article-title":"Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy","volume":"12","author":"Mohabati","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib396","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/eye.2016.53","article-title":"Finasteride is effective for the treatment of central serous chorioretinopathy","volume":"30","author":"Moisseiev","year":"2016","journal-title":"Eye"},{"issue":"Pt 2","key":"10.1016\/j.preteyeres.2024.101236_bib397","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/eye.1999.41","article-title":"Clinical applications of the micropulse diode laser","volume":"13","author":"Moorman","year":"1999","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib398","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddac020","article-title":"Tnfrsf10a downregulation induces retinal pigment epithelium degeneration during the pathogenesis of age-related macular degeneration and central serous chorioretinopathy","author":"Mori","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2024.101236_bib399","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s10384-022-00945-w","article-title":"Association between central serous chorioretinopathy susceptibility genes and choroidal parameters","volume":"66","author":"Morino","year":"2022","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib400","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/IAE.0000000000000693","article-title":"Prevalence of the complement factor h and gstm1 genes polymorphisms in patients with central serous chorioretinopathy","volume":"36","author":"Moschos","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib401","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1055\/s-0029-1245251","article-title":"Fluorescein and indocyanine green angiography findings in b cell lymphoblastic leukemia mimicking acute central serous chorioretinopathy","volume":"227","author":"Moulin","year":"2010","journal-title":"Klin. Monbl. Augenheilkd."},{"key":"10.1016\/j.preteyeres.2024.101236_bib402","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2018.12.048","article-title":"Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy","volume":"126","author":"Mrejen","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib403","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00417-018-4031-8","article-title":"Navigated laser photocoagulation in patients with non-resolving and chronic central serous chorioretinopathy","volume":"256","author":"Muller","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"Suppl. 1","key":"10.1016\/j.preteyeres.2024.101236_bib404","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/ICB.0000000000000383","article-title":"Paraneoplastic vitelliform maculopathy in the setting of choroidal melanoma: evolution over one year","volume":"11","author":"Nagiel","year":"2017","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib405","first-page":"1949","article-title":"Correlation of spectral domain optical coherence tomography findings in acute central serous chorioretinopathy with visual acuity","volume":"6","author":"Nair","year":"2012","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib406","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/IAE.0b013e318183589c","article-title":"Macular complications on the border of an inferior staphyloma associated with tilted disc syndrome","volume":"28","author":"Nakanishi","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib407","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.5664\/jcsm.9312","article-title":"Obstructive sleep apnea and the retina: a review","volume":"17","author":"Nakayama","year":"2021","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.preteyeres.2024.101236_bib408","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archopht.1984.01040030359038","article-title":"Experimental serous retinal detachment and focal pigment epithelial damage","volume":"102","author":"Negi","year":"1984","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib409","doi-asserted-by":"crossref","DOI":"10.1117\/1.2339815","article-title":"Cell disintegration by laser-induced transient microbubbles and its simultaneous monitoring by interferometry","volume":"11","author":"Neumann","year":"2006","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.preteyeres.2024.101236_bib410","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pdpdt.2016.04.012","article-title":"Half-dose photodynamic therapy for chronic central serous chorioretinopathy: efficacy and safety outcomes in real world","volume":"14","author":"Neves","year":"2016","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.preteyeres.2024.101236_bib411","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/eye.2015.251","article-title":"Photodynamic therapy: current role in the treatment of chorioretinal conditions","volume":"30","author":"Newman","year":"2016","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib412","article-title":"Visualising the choriocapillaris: histology, imaging modalities and clinical research - a review","author":"Ng","year":"2021","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib413","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/1752-1947-5-208","article-title":"Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report","volume":"5","author":"Ng","year":"2011","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib414","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","article-title":"Central serous chorioretinopathy: update on pathophysiology and treatment","volume":"58","author":"Nicholson","year":"2013","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib415","first-page":"1","article-title":"Central serous chorioretinopathy: clinical characteristics associated with visual outcomes","author":"Nicholson","year":"2018","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib416","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","article-title":"The multifunctional choroid","volume":"29","author":"Nickla","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib417","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ajo.2014.01.022","article-title":"Half-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathy","volume":"157","author":"Nicolo","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib418","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ajo.2011.08.015","article-title":"Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathy","volume":"153","author":"Nicolo","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib419","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/IAE.0b013e31821c3ef6","article-title":"Oral mifepristone for chronic central serous chorioretinopathy","volume":"31","author":"Nielsen","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib420","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3341\/kjo.2019.0065","article-title":"Comparison of focal and conventional verteporfin photodynamic therapy for chronic central serous chorioretinopathy","volume":"33","author":"Noh","year":"2019","journal-title":"Korean J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib421","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.4103\/ijo.IJO_3499_20","article-title":"Effect of short-term meditation training in central serous chorioretinopathy","volume":"69","author":"Nongrem","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib422","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/IAE.0000000000001645","article-title":"Changes in central choroidal thickness after treatment of diabetic macular edema with intravitreal bevacizumab correlation with central macular thickness and best-corrected visual acuity","volume":"38","author":"Nourinia","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib423","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00006982-198700730-00005","article-title":"Krypton and argon laser photocoagulation for central serous chorioretinopathy","volume":"7","author":"Novak","year":"1987","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib424","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s41433-018-0029-z","article-title":"Comparison of photodynamic therapy and navigated microsecond laser for chronic central serous chorioretinopathy","volume":"32","author":"Ntomoka","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib425","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1750-1172-2-46","article-title":"Sarcoidosis","volume":"2","author":"Nunes","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.preteyeres.2024.101236_bib426","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2016.05.002","article-title":"Vogt-koyanagi-harada disease","volume":"62","author":"O'Keefe","year":"2017","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib427","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000496682","article-title":"Vogt-koyanagi-harada disease-like uveitis during nivolumab (anti-pd-1 antibody) treatment for metastatic cutaneous malignant melanoma","volume":"10","author":"Obata","year":"2019","journal-title":"Case Rep. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib428","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.ophtha.2005.06.026","article-title":"Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy","volume":"112","author":"Ober","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib429","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3341\/kjo.2020.0112","article-title":"Evaluation of the safety and efficacy of selective retina therapy laser treatment in patients with central serous chorioretinopathy","volume":"35","author":"Oh","year":"2021","journal-title":"Korean J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib430","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1167\/iovs.13-13183","article-title":"Biometric characteristics of eyes with central serous chorioretinopathy","volume":"55","author":"Oh","year":"2014","journal-title":"Investig. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib431","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/archopht.1995.01100030071024","article-title":"Transpupillary thermotherapy in choroidal melanomas","volume":"113","author":"Oosterhuis","year":"1995","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib432","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00417-010-1338-5","article-title":"Thickness of photoreceptor layers in polypoidal choroidal vasculopathy and central serous chorioretinopathy","volume":"248","author":"Ooto","year":"2010","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib433","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0002-9394(99)00033-1","article-title":"Patterns of diabetic macular edema with optical coherence tomography","volume":"127","author":"Otani","year":"1999","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib434","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00006982-200202000-00005","article-title":"A long-term follow-up study of severe variant of central serous chorioretinopathy","volume":"22","author":"Otsuka","year":"2002","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib435","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0420.2005.00387.x","article-title":"Serous macular detachment in diabetic cystoid macular oedema","volume":"83","author":"Ozdemir","year":"2005","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.preteyeres.2024.101236_bib436","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/eye.2016.79","article-title":"The time of resolution and the rate of recurrence in acute central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy: a case-control study","volume":"30","author":"Ozkaya","year":"2016","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib437","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3513794","article-title":"Low-fluence photodynamic therapy versus subthreshold micropulse yellow wavelength laser in the treatment of chronic central serous chorioretinopathy","volume":"2016","author":"Ozmert","year":"2016","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib438","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ncpneuro0847","article-title":"The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders","volume":"4","author":"Pandi-Perumal","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib439","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IAE.0000000000000331","article-title":"Pachychoroid neovasculopathy","volume":"35","author":"Pang","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib440","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ajo.2014.04.021","article-title":"Ultra-widefield imaging with autofluorescence and indocyanine green angiography in central serous chorioretinopathy","volume":"158","author":"Pang","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib441","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/bjophthalmol-2020-316837","article-title":"Optimal fluence rate of photodynamic therapy for chronic central serous chorioretinopathy","volume":"105","author":"Park","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib442","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3341\/kjo.2014.28.4.306","article-title":"Intravitreal anti-vascular endothelial growth factor versus observation in acute central serous chorioretinopathy: one-year results","volume":"28","author":"Park","year":"2014","journal-title":"Korean J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib443","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s00417-019-04426-8","article-title":"Comparing effects of photodynamic therapy in central serous chorioretinopathy: full-dose versus half-dose versus half-dose-half-fluence","volume":"257","author":"Park","year":"2019","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib444","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00417-017-3672-3","article-title":"Selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy in Korean patients","volume":"255","author":"Park","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib445","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3928\/23258160-20191119-03","article-title":"Long-term efficacy and safety of photodynamic therapy in patients with chronic central serous chorioretinopathy","volume":"50","author":"Park","year":"2019","journal-title":"Ophthal. Surg., Lasers Imag. Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib446","first-page":"71","article-title":"Argon laser photocoagulation in macular diseases","volume":"69","author":"Patz","year":"1971","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.preteyeres.2024.101236_bib447","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0000000000003807","article-title":"Single-session bilateral reduced-settings photodynamic therapy for bilateral chronic central serous chorioretinopathy","author":"Pauleikhoff","year":"2023","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib448","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ajo.2005.10.042","article-title":"Back pain after photodynamic therapy with verteporfin","volume":"141","author":"Pece","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib449","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1097\/IAE.0000000000001750","article-title":"Anti-vascular endothelial growth factor therapy versus photodynamic therapy in the treatment of choroidal neovascularization secondary to central serous chorioretinopathy","volume":"38","author":"Peiretti","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib450","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/IAE.0000000000000529","article-title":"Choroidal neovascularization in caucasian patients with longstanding central serous chorioretinopathy","volume":"35","author":"Peiretti","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib451","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1097\/IAE.0000000000002234","article-title":"Optical coherence tomography angiography characteristics of polypoidal choroidal vasculopathy secondary to chronic central serous chorioretinopathy","volume":"39","author":"Peiretti","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib452","article-title":"Longitudinal multimodal functional macular analysis after half-dose photodynamic therapy for central serous chorioretinopathy","volume":"37","author":"Penas","year":"2021","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.preteyeres.2024.101236_bib453","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/bjo.2006.109702","article-title":"Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells","volume":"91","author":"Peters","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib454","article-title":"Eplerenone for the treatment of chronic central serous chorioretinopathy: 3-year clinical experience","author":"Petkovsek","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib455","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/bjophthalmol-2019-314047","article-title":"Eplerenone for the treatment of chronic central serous chorioretinopathy: 3-year clinical experience","volume":"104","author":"Petkovsek","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib456","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99977-4","article-title":"Estimation of current and post-treatment retinal function in chronic central serous chorioretinopathy using artificial intelligence","volume":"11","author":"Pfau","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib457","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1097\/IAE.0000000000001907","article-title":"Peripapillary pachychoroid syndrome","volume":"38","author":"Phasukkijwatana","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib458","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4604567","article-title":"Comparison of 532 nm micropulse green laser versus continuous-wave 532 nm green laser in chronic central serous chorioretinopathy: long-term follow-up","volume":"2020","author":"Piasecka","year":"2020","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib459","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/IAE.0b013e31816b4b86","article-title":"Posterior cystoid retinal degeneration in central serous chorioretinopathy","volume":"28","author":"Piccolino","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib460","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12886-020-01796-0","article-title":"One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy","volume":"21","author":"Pichai","year":"2021","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib461","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s10792-016-0377-2","article-title":"Comparison of two mineralcorticosteroids receptor antagonists for the treatment of central serous chorioretinopathy","volume":"37","author":"Pichi","year":"2017","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib462","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0002-9394(02)01685-9","article-title":"Optical coherence tomography findings in adult-onset foveomacular vitelliform dystrophy","volume":"134","author":"Pierro","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib463","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0161-6420(02)01157-0","article-title":"Acetazolamide for central serous retinopathy","volume":"109","author":"Pikkel","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib464","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/08820538.2021.1931357","article-title":"Foveal and extrafoveal effects of half-dose photodynamic therapy in chronic central serous chorioretinopathy: a cohort study","volume":"37","author":"Pinto","year":"2022","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib465","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/bjophthalmol-2014-306018","article-title":"A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the contain study","volume":"99","author":"Pitcher","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib466","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2024.101236_bib467","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/bjo.79.10.922","article-title":"Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment","volume":"79","author":"Polak","year":"1995","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib468","article-title":"Utility of optical coherence tomography angiography in pregnancy-associated central serous chorioretinopathy","volume":"20","author":"Pole","year":"2020","journal-title":"Am. J. Ophthalmol. Case Rep"},{"key":"10.1016\/j.preteyeres.2024.101236_bib469","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/ICB.0000000000001211","article-title":"Potential treatment for peripapillary pachychoroid syndrome","volume":"17","author":"Pothof","year":"2023","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib470","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112418","article-title":"Influence of retinal microsecond pulse laser treatment in central serous chorioretinopathy: a short-term optical coherence tomography angiography study","volume":"10","author":"Prasuhn","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2024.101236_bib471","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/bjo.72.9.646","article-title":"Birdshot chorioretinopathy: clinical characteristics and evolution","volume":"72","author":"Priem","year":"1988","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib472","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9394(14)70531-8","article-title":"Choroidal capillary and venous congestion in central serous chorioretinopathy","volume":"121","author":"Prunte","year":"1996","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib473","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1755-3768.2011.02157.x","article-title":"Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy","volume":"90","author":"Pryds","year":"2012","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib474","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.ophtha.2007.03.019","article-title":"Vitelliform macular dystrophy","volume":"114","author":"Querques","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib475","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ajo.2011.01.047","article-title":"Natural course of adult-onset foveomacular vitelliform dystrophy: a spectral-domain optical coherence tomography analysis","volume":"152","author":"Querques","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib476","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00417-004-1099-0","article-title":"Viagra-associated serous macular detachment","volume":"243","author":"Quiram","year":"2005","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib477","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/eye.2017.290","article-title":"Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy","volume":"32","author":"Rabiolo","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib478","first-page":"99","article-title":"The effect of helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy","volume":"17","author":"Rahbani-Nobar","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2024.101236_bib479","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/IAE.0000000000001649","article-title":"A randomized double-blind placebo-control pilot study of eplerenone for the treatment of central serous chorioretinopathy (ecselsior)","volume":"38","author":"Rahimy","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib480","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.survophthal.2012.09.001","article-title":"Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management","volume":"58","author":"Rahimy","year":"2013","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib481","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.jfo.2012.05.006","article-title":"Circumscribed choroidal haemangioma mimicking chronic central serous chorioretinopathy","volume":"36","author":"Rahman","year":"2013","journal-title":"J. Fr. Ophtalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib482","series-title":"Photodynamic Therapy for the Eye","author":"Raizada","year":"2022"},{"key":"10.1016\/j.preteyeres.2024.101236_bib483","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3928\/23258160-20180628-03","article-title":"Predictors of outcome during eplerenone therapy in chronic central serous chorioretinopathy:A prospective, open-label pilot clinical study","volume":"49","author":"Rajesh","year":"2018","journal-title":"Ophthal. Surg., Lasers Imag. Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib484","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0000000000003826","article-title":"Stellate multiform amelanotic choroidopathy (smach). Clinical and multimodal imaging features","author":"Ramtohul","year":"2023","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib485","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/ICB.0b013e3181aff523","article-title":"Successful treatment of choroidal neovascularization complicating a choroidal osteoma with intravitreal bevacizumab","volume":"4","author":"Rao","year":"2010","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib486","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2415-12-20","article-title":"High-dose antioxidants for central serous chorioretinopathy; the randomized placebo-controlled study","volume":"12","author":"Ratanasukon","year":"2012","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib487","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1097\/IAE.0000000000003297","article-title":"Myopic presentation of central serous chorioretinopathy","volume":"41","author":"Ravenstijn","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib488","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.2174\/1381612826666200609164830","article-title":"Synergistic antioxidant and antibacterial activity of curcumin-c3 encapsulated chitosan nanoparticles","volume":"26","author":"Reddy","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.preteyeres.2024.101236_bib489","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1136\/bjophthalmol-2016-310023","article-title":"Poppers: legal highs with questionable contents? A case series of poppers maculopathy","volume":"101","author":"Rewbury","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib490","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00417-003-0850-2","article-title":"Optical coherence tomographic findings in pregnancy-associated central serous chorioretinopathy","volume":"242","author":"Rezai","year":"2004","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib491","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00417-008-1014-1","article-title":"Indocyanine green enhanced subthreshold diode-laser micropulse photocoagulation treatment of chronic central serous chorioretinopathy","volume":"247","author":"Ricci","year":"2009","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib492","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1001\/jamaophthalmol.2018.3293","article-title":"Association of corticosteroid use with incidence of central serous chorioretinopathy in South Korea","volume":"136","author":"Rim","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib493","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2147\/OPTH.S16947","article-title":"Foveal atrophy and macular hole formation following intravitreal ranibizumab with\/without photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration","volume":"5","author":"Rishi","year":"2011","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib494","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0161-6420(86)33652-2","article-title":"Argon laser photocoagulation treatment in central serous chorioretinopathy","volume":"93","author":"Robertson","year":"1986","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib495","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0002-9394(83)90265-9","article-title":"Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy","volume":"95","author":"Robertson","year":"1983","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib496","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/bjophthalmol-2017-311291","article-title":"Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the pan-american collaborative retina study (pacores) group","volume":"102","author":"Roca","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib497","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/archopht.117.8.1028","article-title":"Retinal sparing by selective retinal pigment epithelial photocoagulation","volume":"117","author":"Roider","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib498","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1001\/archopht.1992.01080240126045","article-title":"Response of the retinal pigment epithelium to selective photocoagulation","volume":"110","author":"Roider","year":"1992","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib499","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3928\/23258160-20130909-08","article-title":"Micropulse diode laser treatment for chronic central serous chorioretinopathy: a randomized pilot trial","volume":"44","author":"Roisman","year":"2013","journal-title":"Ophthal. Surg., Lasers Imag. Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib500","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1055\/a-0834-6118","article-title":"Choroidal neovascularisation complicating chronic central serous chorioretinopathy: the discovery rate on multimodal imaging","volume":"236","author":"Romdhane","year":"2019","journal-title":"Klinisch. Monatsbl. Augenheilk."},{"key":"10.1016\/j.preteyeres.2024.101236_bib501","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/bjophthalmol-2019-314625","article-title":"Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-vegf) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy","volume":"104","author":"Romdhane","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib502","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1097\/IAE.0000000000001027","article-title":"Choroidal thickness changes in proliferative diabetic retinopathy treated with panretinal photocoagulation versus panretinal photocoagulation with intravitreal bevacizumab","volume":"36","author":"Roohipoor","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib503","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/archopht.1992.01080220020005","article-title":"Solitary hypopigmented nevus of the retinal pigment epithelium in the macula","volume":"110","author":"Roseman","year":"1992","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib504","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/08820538.2016.1182556","article-title":"Variation in visual outcome to anti-vascular endothelial growth factors in choroidal neovascular membrane developing in eyes with previously untreated versus focal laser-treated central serous chorioretinopathy","volume":"32","author":"Roy","year":"2017","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib505","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1755-3768.2008.01408.x","article-title":"Photodynamic therapy for chronic central serous chorioretinopathy","volume":"88","author":"Ruiz-Moreno","year":"2010","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib506","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00417-017-3626-9","article-title":"Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy","volume":"255","author":"Russo","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib507","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/eye.2017.295","article-title":"Response of central serous chorioretinopathy evaluated by multimodal retinal imaging","volume":"32","author":"Sacconi","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib508","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1038\/s41433-019-0511-2","article-title":"Early response to the treatment of choroidal neovascularization complicating central serous chorioretinopathy: a oct-angiography study","volume":"33","author":"Sacconi","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib509","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/08820538.2013.793728","article-title":"Psychological distress and poor quality of life in patients with central serous chorioretinopathy","volume":"29","author":"Sahin","year":"2014","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib510","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1136\/bjophthalmol-2018-313048","article-title":"Optical coherence tomography angiography findings in cystoid macular degeneration associated with central serous chorioretinopathy","volume":"103","author":"Sahoo","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib511","article-title":"Interobserver agreement of novel classification of central serous chorioretinopathy","volume":"14","author":"Sahoo","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.preteyeres.2024.101236_bib512","doi-asserted-by":"crossref","DOI":"10.3390\/ph13090221","article-title":"Bullous central serous chorioretinopathy: a rare and atypical form of central serous chorioretinopathy. A systematic review","volume":"13","author":"Sartini","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.preteyeres.2024.101236_bib513","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/IAE.0000000000002810","article-title":"The incidence of neovascularization in central serous chorioretinopathy by optical coherence tomography angiography","volume":"41","author":"Savastano","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib514","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100124","article-title":"Scleral thickness in steroid-induced central serous chorioretinopathy","volume":"2","author":"Sawaguchi","year":"2022","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib515","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0161-6420(95)30908-6","article-title":"Subretinal fibrosis in central serous chorioretinopathy","volume":"102","author":"Schatz","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib516","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/jamaophthalmol.2018.3190","article-title":"Role of the complement system in chronic central serous chorioretinopathy: a genome-wide association study","volume":"136","author":"Schellevis","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib517","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.576","article-title":"Exome sequencing in families with chronic central serous chorioretinopathy","volume":"7","author":"Schellevis","year":"2019","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.preteyeres.2024.101236_bib518","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s00417-002-0517-4","article-title":"Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes","volume":"240","author":"Schlotzer-Schrehardt","year":"2002","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib519","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0039-6257(00)00158-2","article-title":"Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration","volume":"45","author":"Schmidt-Erfurth","year":"2000","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib520","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/archopht.123.10.1347","article-title":"Complications after photodynamic therapy","volume":"123","author":"Schnurrbusch","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib521","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/eye.2016.142","article-title":"Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy","volume":"30","author":"Scholz","year":"2016","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib522","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000439600","article-title":"Subthreshold micropulse laser (577 nm) treatment in chronic central serous chorioretinopathy","volume":"234","author":"Scholz","year":"2015","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2024.101236_bib523","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/humu.22551","article-title":"Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathy","volume":"35","author":"Schubert","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.preteyeres.2024.101236_bib524","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1111\/aos.13491","article-title":"Eplerenone for chronic central serous chorioretinopathy-a randomized controlled prospective study","volume":"95","author":"Schwartz","year":"2017","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib525","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00417-020-04623-w","article-title":"Response of neovascular central serous chorioretinopathy to an extended upload of anti-vegf agents","volume":"258","author":"Schworm","year":"2020","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib526","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1007\/s00417-021-05256-3","article-title":"Subthreshold laser therapy with a standardized macular treatment pattern in chronic central serous chorioretinopathy","volume":"259","author":"Schworm","year":"2021","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib527","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1117\/1.JBO.23.11.115002","article-title":"Selective retina therapy: toward an optically controlled automatic dosing","volume":"23","author":"Seifert","year":"2018","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.preteyeres.2024.101236_bib528","doi-asserted-by":"crossref","DOI":"10.1016\/j.pacs.2021.100316","article-title":"Algorithms for optoacoustically controlled selective retina therapy (srt)","volume":"25","author":"Seifert","year":"2022","journal-title":"Photoacoustics"},{"key":"10.1016\/j.preteyeres.2024.101236_bib529","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s10384-012-0162-3","article-title":"Intravitreal bevacizumab versus low-fluence photodynamic therapy for treatment of chronic central serous chorioretinopathy","volume":"56","author":"Semeraro","year":"2012","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib530","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11051443","article-title":"Angiography fractal analysis of choroidal neovessels secondary to central serous chorioretinopathy, in a caucasian cohort","volume":"11","author":"Serra","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2024.101236_bib531","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1007\/s00417-016-3378-y","article-title":"Circadian disturbance and idiopathic central serous chorioretinopathy","volume":"254","author":"Setrouk","year":"2016","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib532","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00417-018-4086-6","article-title":"Half-time photodynamic therapy in treatment of chronic central serous chorioretinopathy","volume":"256","author":"Sheptulin","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib533","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/IAE.0000000000000376","article-title":"Choroidal osteoma shows bone lamella and vascular channels on enhanced depth imaging optical coherence tomography in 15 eyes","volume":"35","author":"Shields","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib534","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1097\/IAE.0000000000002440","article-title":"Choroidal nevus imaging features in 3,806 cases and risk factors for transformation into melanoma in 2,355 cases: the 2020 taylor r. Smith and victor t. Curtin lecture","volume":"39","author":"Shields","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib535","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/S0161-6420(01)00812-0","article-title":"Circumscribed choroidal hemangioma: clinical manifestations and factors predictive of visual outcome in 200 consecutive cases","volume":"108","author":"Shields","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib536","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/j.ophtha.2007.07.037","article-title":"Optical coherence tomography of choroidal osteoma in 22 cases: evidence for photoreceptor atrophy over the decalcified portion of the tumor","volume":"114","author":"Shields","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib537","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archopht.1997.01100150205010","article-title":"Plaque radiotherapy for the management of uveal metastasis","volume":"115","author":"Shields","year":"1997","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib538","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0161-6420(97)30148-1","article-title":"Survey of 520 eyes with uveal metastases","volume":"104","author":"Shields","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib539","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/IAE.0b013e3181e378f2","article-title":"Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy","volume":"31","author":"Shin","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib540","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3341\/kjo.2015.29.6.389","article-title":"Comparison of the clinical manifestations between acute vogt-koyanagi-harada disease and acute bilateral central serous chorioretinopathy","volume":"29","author":"Shin","year":"2015","journal-title":"Korean J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib541","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s10384-019-00697-0","article-title":"Long-term results of focal laser photocoagulation and photodynamic therapy for the treatment of central serous chorioretinopathy","volume":"64","author":"Shin","year":"2020","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib542","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/IAE.0b013e3181c70203","article-title":"Morphologic findings in acute central serous chorioretinopathy using spectral domain-optical coherence tomography with simultaneous angiography","volume":"30","author":"Shinojima","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib543","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1097\/IAE.0000000000000621","article-title":"Comparison of halving the irradiation time or the verteporfin dose in photodynamic therapy for chronic central serous chorioretinopathy","volume":"35","author":"Shiode","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib544","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2018.06.009","article-title":"Clinical features of central serous chorioretinopathy with type 1 choroidal neovascularization","author":"Shiragami","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib545","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/s41433-018-0074-7","article-title":"Torpedo maculopathy: disease spectrum and associated choroidal neovascularisation in a paediatric population","volume":"32","author":"Shirley","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib546","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/sj.eye.6702449","article-title":"Transpupillary thermotherapy for subfoveal leaks in central serous chorioretinopathy","volume":"22","author":"Shukla","year":"2008","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib547","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00417-015-2989-z","article-title":"Oral rifampin treatment for longstanding chronic central serous chorioretinopathy","volume":"254","author":"Shulman","year":"2016","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib548","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.oret.2022.04.004","article-title":"Progression of pachychoroid neovasculopathy into aneurysmal type 1 choroidal neovascularization or polypoidal choroidal vasculopathy","volume":"6","author":"Siedlecki","year":"2022","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib549","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.oret.2019.08.002","article-title":"The pachychoroid disease spectrum-and the need for a uniform classification system","volume":"3","author":"Siedlecki","year":"2019","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib550","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/IAE.0b013e3182670fbe","article-title":"Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study","volume":"33","author":"Silva","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib551","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2147\/OPTH.S260998","article-title":"Oral spironolactone versus conservative treatment for non-resolving central serous chorioretinopathy in real-life practice","volume":"14","author":"Sinawat","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib552","article-title":"Central serous chorioretinopathy imaging biomarkers","author":"Singh","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib553","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/bjophthalmol-2018-312435","article-title":"Discrepancy in current central serous chorioretinopathy classification","volume":"103","author":"Singh","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib554","doi-asserted-by":"crossref","first-page":"e1522","DOI":"10.1111\/aos.15148","article-title":"Clinical impact of the worldwide shortage of verteporfin (visudyne(r)) on ophthalmic care","volume":"100","author":"Sirks","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib555","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.survophthal.2010.02.005","article-title":"Micropulsed diode laser therapy: evolution and clinical applications","volume":"55","author":"Sivaprasad","year":"2010","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib556","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/S0161-6420(97)30022-0","article-title":"Indocyanine green angiography of multifocal choroiditis","volume":"104","author":"Slakter","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib557","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000490773","article-title":"Long-term outcomes of full-fluence and half-fluence photodynamic therapy for chronic central serous chorioretinopathy","volume":"241","author":"Son","year":"2019","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2024.101236_bib558","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ajo.2012.02.031","article-title":"Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography","volume":"154","author":"Song","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib559","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/IAE.0b013e3181c720ca","article-title":"Intravitreal bevacizumab in the management of subretinal fluid associated with choroidal osteoma","volume":"30","author":"Song","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib560","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.09.010427","article-title":"Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors","volume":"9","author":"Song","year":"2019","journal-title":"J. Glob. Health"},{"key":"10.1016\/j.preteyeres.2024.101236_bib561","article-title":"Short-term effect of anti-vegf for chronic central serous chorioretinopathy according to the presence of choroidal neovascularization using optical coherence tomography angiography","volume":"16","author":"Song","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.preteyeres.2024.101236_bib562","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/eye.2018.2","article-title":"The use of optical coherence tomography angiography for detecting choroidal neovascularization, compared to standard multimodal imaging","volume":"32","author":"Soomro","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib563","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2147\/OPTH.S232202","article-title":"532-nm subthreshold micropulse laser for the treatment of chronic central serous retinopathy","volume":"14","author":"Sousa","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib564","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/IAE.0b013e318158eca4","article-title":"Autofluorescence from the outer retina and subretinal space: hypothesis and review","volume":"28","author":"Spaide","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib565","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00006982-200404000-00019","article-title":"Deposition of yellow submacular material in central serous chorioretinopathy resembling adult-onset foveomacular vitelliform dystrophy","volume":"24","author":"Spaide","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib566","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1097\/IAE.0000000000002931","article-title":"Choroidal blood flow: review and potential explanation for the choroidal venous anatomy including the vortex vein system","volume":"40","author":"Spaide","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib567","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/IAE.0000000000003057","article-title":"The ambiguity of pachychoroid","volume":"41","author":"Spaide","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib568","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0161-6420(96)30386-2","article-title":"Central serous chorioretinopathy in younger and older adults","volume":"103","author":"Spaide","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib569","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100973","article-title":"Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders","volume":"86","author":"Spaide","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib570","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00006982-199616030-00004","article-title":"Indocyanine green videoangiography of older patients with central serous chorioretinopathy","volume":"16","author":"Spaide","year":"1996","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib571","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ophtha.2005.01.003","article-title":"Fundus autofluorescence and central serous chorioretinopathy","volume":"112","author":"Spaide","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib572","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ajo.2015.08.018","article-title":"Loculation of fluid in the posterior choroid in eyes with central serous chorioretinopathy","volume":"160","author":"Spaide","year":"2015","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib573","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00006982-199515020-00003","article-title":"Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy","volume":"15","author":"Spaide","year":"1995","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib574","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF02150023","article-title":"Pathogenesis of central serous retinopathy: a new working hypothesis","volume":"224","author":"Spitznas","year":"1986","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib575","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1167\/iovs.10-5917","article-title":"Non-damaging retinal phototherapy: dynamic range of heat shock protein expression","volume":"52","author":"Sramek","year":"2011","journal-title":"Investig. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib576","article-title":"Retinal detachment","author":"Steel","year":"2014","journal-title":"BMJ Clin. Evid."},{"key":"10.1016\/j.preteyeres.2024.101236_bib577","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/bjo.2006.093328","article-title":"Half dose verteporfin pdt for central serous chorioretinopathy","volume":"90","author":"Stewart","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib578","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s40123-023-00658-4","article-title":"Risk of central serous chorioretinopathy in male androgen abusers","volume":"12","author":"Subhi","year":"2023","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.preteyeres.2024.101236_bib579","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00417-019-04297-z","article-title":"Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (csc) diagnosed by swept source optical coherence tomography angiography (ss octa)","volume":"257","author":"Sulzbacher","year":"2019","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib580","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/bjophthalmol-2017-311096","article-title":"Spironolactone versus observation in the treatment of acute central serous chorioretinopathy","volume":"102","author":"Sun","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib581","article-title":"Efficacy and safety of subthreshold micropulse laser compared with threshold conventional laser in central serous chorioretinopathy","author":"Sun","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib582","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41433-019-0692-8","article-title":"Efficacy and safety of subthreshold micropulse laser compared with threshold conventional laser in central serous chorioretinopathy","volume":"34","author":"Sun","year":"2020","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib583","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0039-6257(88)90172-5","article-title":"The pregnant woman's eye","volume":"32","author":"Sunness","year":"1988","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib584","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10633-014-9443-0","article-title":"Occult macular dystrophy with bilateral chronic subfoveal serous retinal detachment associated with a novel rp1l1 mutation (p.S1199p)","volume":"129","author":"Takahashi","year":"2014","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib585","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12886-022-02487-8","article-title":"Case series: pachychoroid pigment epitheliopathy transformed to polypoidal choroidal vasculopathy after long-term follow-up","volume":"22","author":"Tang","year":"2022","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib586","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/jop.2006.22.145","article-title":"The use of propranolol to treat central serous chorioretinopathy: an evaluation by serial oct","volume":"22","author":"Tatham","year":"2006","journal-title":"J. Ocul. Pharmacol. Therap."},{"key":"10.1016\/j.preteyeres.2024.101236_bib587","first-page":"350","article-title":"Comparison of autofluorescence and optical coherence tomography findings in acute and chronic central serous chorioretinopathy","volume":"7","author":"Teke","year":"2014","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib588","first-page":"265","article-title":"Intravitreal bevacizumab and ranibizumab in the treatment of acute central serous chorioretihopathy: a single center retrospective study","volume":"33","author":"Tekin","year":"2018","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib589","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib590","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2021.100071","article-title":"Short axial length is related to asymmetric vortex veins in central serous chorioretinopathy","volume":"1","author":"Terao","year":"2021","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib591","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/IAE.0000000000003376","article-title":"Ciliochoroidal effusion in central serous chorioretinopathy","volume":"42","author":"Terao","year":"2022","journal-title":"Retina"},{"issue":"9","key":"10.1016\/j.preteyeres.2024.101236_bib592","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1136\/bjophthalmol-2019-315236","article-title":"Short axial length and hyperopic refractive error are risk factors of central serous chorioretinopathy","volume":"104","author":"Terao","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib593","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1167\/iovs.15-17140","article-title":"Angiography compared to fluorescein and indocyanine green angiography in chronic central serous chorioretinopathy","volume":"56","author":"Teussink","year":"2015","journal-title":"Investig. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib594","series-title":"Physiology, Cortisol, Statpearls, Treasure Island (FL)","author":"Thau","year":"2023"},{"key":"10.1016\/j.preteyeres.2024.101236_bib595","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/bjo.67.2.102","article-title":"Irreversible visual loss in waldenstrom's macroglobulinaemia","volume":"67","author":"Thomas","year":"1983","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib596","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archopht.121.7.975","article-title":"Topical fundus pulsation measurement in patients with active central serous chorioretinopathy","volume":"121","author":"Tittl","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib597","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0002-9394(99)00075-6","article-title":"Systemic findings associated with central serous chorioretinopathy","volume":"128","author":"Tittl","year":"1999","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib598","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00417-008-0856-x","article-title":"A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (case reports)","volume":"246","author":"Torres-Soriano","year":"2008","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib599","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/IAE.0000000000000159","article-title":"Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: a population-based study in taiwan","volume":"34","author":"Tsai","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib600","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/OPX.0000000000000360","article-title":"Half-time photodynamic therapy for central serous chorioretinopathy","volume":"91","author":"Tsai","year":"2014","journal-title":"Optometry Vis. Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib601","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/bjophthalmol-2014-305353","article-title":"Long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy","volume":"99","author":"Tseng","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib602","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/eye.2012.66","article-title":"Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy","volume":"26","author":"Uetani","year":"2012","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib603","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/2008-322X.180700","article-title":"Intravitreal bevacizumab for treatment of central serous chorioretinopathy","volume":"11","author":"Unlu","year":"2016","journal-title":"J. Ophthal. Vis. Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib604","doi-asserted-by":"crossref","first-page":"308","DOI":"10.5935\/0004-2749.20160088","article-title":"Subfoveal choroidal thickness changes after intravitreal bevacizumab therapy for central serous chorioretinopathy","volume":"79","author":"Unlu","year":"2016","journal-title":"Arquivos Brasil. Oftalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib605","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdu169","article-title":"Transient mek inhibitor-associated retinopathy in metastatic melanoma","volume":"25","author":"Urner-Bloch","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib606","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0161-6420(99)00141-4","article-title":"Uveal effusion syndrome: clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology","volume":"107","author":"Uyama","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib607","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10103-020-03129-5","article-title":"The efficacy of subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy","volume":"36","author":"Uzlu","year":"2021","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib608","doi-asserted-by":"crossref","first-page":"442","DOI":"10.5301\/ejo.5000790","article-title":"Chronic central serous chorioretinopathy as a presenting symptom of cushing syndrome","volume":"26","author":"van Dijk","year":"2016","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib609","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1007\/s00417-016-3417-8","article-title":"Central serous chorioretinopathy in primary hyperaldosteronism","volume":"254","author":"van Dijk","year":"2016","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib610","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.ophtha.2015.05.027","article-title":"Serous retinopathy associated with mitogen-activated protein kinase kinase inhibition (binimetinib) for metastatic cutaneous and uveal melanoma","volume":"122","author":"van Dijk","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib611","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100955","article-title":"Serous business: delineating the broad spectrum of diseases with subretinal fluid in the macula","volume":"84","author":"van Dijk","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib612","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/aos.14995","article-title":"Serous maculopathy with absence of retinal pigment epithelium (smarpe)","volume":"100","author":"van Dijk","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib613","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1007\/s00417-017-3720-z","article-title":"Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea","volume":"255","author":"van Dijk","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib614","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/ICB.0000000000000498","article-title":"Short-term findings on optical coherence tomography and microperimetry in chronic central serous chorioretinopathy patients treated with half-dose photodynamic therapy","volume":"12","author":"van Dijk","year":"2018","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib615","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","article-title":"Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the place trial","volume":"125","author":"van Dijk","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib616","article-title":"Comparative efficacy of treatments for chronic central serous chorioretinopathy: a systematic review with network meta-analyses","author":"van Dijk","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib617","article-title":"Serous maculopathy due to aspecific choroidopathy (smach)","author":"van Dijk","year":"2022","journal-title":"Asia-Pac. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib618","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/IAE.0000000000001966","article-title":"Familial central serous chorioretinopathy","volume":"39","author":"van Dijk","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib619","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/jamaophthalmol.2017.0245","article-title":"Association of a haplotype in the nr3c2 gene, encoding the mineralocorticoid receptor, with chronic central serous chorioretinopathy","volume":"135","author":"van Dijk","year":"2017","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib620","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40123-020-00250-0","article-title":"Photodynamic therapy for chorioretinal diseases: a practical approach","volume":"9","author":"van Dijk","year":"2020","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.preteyeres.2024.101236_bib621","article-title":"Maladaptive personality traits, psychological morbidity and coping strategies in chronic central serous chorioretinopathy","author":"van Haalen","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib622","doi-asserted-by":"crossref","first-page":"e572","DOI":"10.1111\/aos.13952","article-title":"Maladaptive personality traits, psychological morbidity and coping strategies in chronic central serous chorioretinopathy","volume":"97","author":"van Haalen","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib623","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fendo.2018.00039","article-title":"Cushing's syndrome and hypothalamic-pituitary-adrenal axis hyperactivity in chronic central serous chorioretinopathy","volume":"9","author":"van Haalen","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib624","article-title":"Hair cortisol concentrations in chronic central serous chorioretinopathy","author":"van Haalen","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib625","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1097\/IAE.0000000000003157","article-title":"Response of choroidal abnormalities to photodynamic therapy versus micropulse laser in chronic central serous chorioretinopathy: place trial report no. 4","volume":"41","author":"van Rijssen","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib626","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202549","article-title":"Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy","volume":"13","author":"van Rijssen","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.preteyeres.2024.101236_bib627","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00417-018-4003-z","article-title":"Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy","volume":"256","author":"van Rijssen","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib628","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2019.03.025","article-title":"Focal and diffuse chronic central serous chorioretinopathy treated with half-dose photodynamic therapy or subthreshold micropulse laser: place trial report no. 3","volume":"205","author":"van Rijssen","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib629","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ajo.2019.11.022","article-title":"Reply to comment on: focal and diffuse chronic central serous chorioretinopathy treated with half-dose photodynamic therapy or subthreshold micropulse laser: place trial report no. 3","volume":"212","author":"van Rijssen","year":"2020","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib630","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/aos.14775","article-title":"Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser","volume":"99","author":"van Rijssen","year":"2021","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib631","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajo.2020.04.007","article-title":"Crossover to photodynamic therapy or micropulse laser after failure of primary treatment of chronic central serous chorioretinopathy: the replace trial","volume":"216","author":"van Rijssen","year":"2020","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib632","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00417-020-04959-3","article-title":"Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy","volume":"259","author":"van Rijssen","year":"2021","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib633","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajo.2021.06.020","article-title":"Half-dose photodynamic therapy versus eplerenone in chronic central serous chorioretinopathy (spectra): a randomized controlled trial","volume":"233","author":"van Rijssen","year":"2022","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib634","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: towards an evidence-based treatment guideline","volume":"73","author":"van Rijssen","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib635","article-title":"Multimodal imaging in hellp-related chorioretinopathy","author":"Van Rysselberge","year":"2020","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib636","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00417-013-2270-2","article-title":"Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy","volume":"251","author":"Vasconcelos","year":"2013","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib637","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mehy.2018.02.024","article-title":"Clinical manifestations of pachychoroid may be secondary to pachysclera and increased scleral rigidity","volume":"113","author":"Venkatesh","year":"2018","journal-title":"Med. Hypoth."},{"key":"10.1016\/j.preteyeres.2024.101236_bib638","doi-asserted-by":"crossref","DOI":"10.1177\/2515841418807130","article-title":"Efficacy of oral rifampicin in chronic central serous chorioretinopathy","volume":"10","author":"Venkatesh","year":"2018","journal-title":"Therap. Adv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib639","doi-asserted-by":"crossref","DOI":"10.3390\/ph13080170","article-title":"Oral eplerenone versus observation in the management of acute central serous chorioretinopathy: a prospective, randomized comparative study","volume":"13","author":"Venkatesh","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.preteyeres.2024.101236_bib640","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2415-4-15","article-title":"Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: a pilot, randomized controlled trial [isrctn84128484]","volume":"4","author":"Verma","year":"2004","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib641","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/bjophthalmol-2020-316992","article-title":"Focal choroidal excavation: review of literature","volume":"105","author":"Verma","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib642","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/08820538.2020.1809682","article-title":"Subthreshold micro-pulse yellow laser and eplerenone drug therapy in chronic central serous chorio-retinopathy patients: a comparative study","volume":"35","author":"Vignesh","year":"2020","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib643","doi-asserted-by":"crossref","first-page":"24100","DOI":"10.1073\/pnas.1914143116","article-title":"Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration","volume":"116","author":"Voigt","year":"2019","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2024.101236_bib644","first-page":"211","article-title":"Ueber centale recidiverende retinitis. v","volume":"12","author":"von Graefe","year":"1866","journal-title":"Graefes Arch. Ophthal."},{"key":"10.1016\/j.preteyeres.2024.101236_bib645","first-page":"7","article-title":"Diffuse retinal pigment epitheliopathy. Ophthalmologica","volume":"185","author":"von Winning","year":"1982"},{"key":"10.1016\/j.preteyeres.2024.101236_bib646","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00417-003-0650-8","article-title":"Concentric retinal pigment epithelium atrophy after a single photodynamic therapy","volume":"241","author":"Wachtlin","year":"2003","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib647","doi-asserted-by":"crossref","DOI":"10.3390\/ph14010053","article-title":"Morphological changes and prognostic factors before and after photodynamic therapy for central serous chorioretinopathy","volume":"14","author":"Wakatsuki","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.preteyeres.2024.101236_bib648","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0420.2007.00889.x","article-title":"Central serous chorioretinopathy","volume":"86","author":"Wang","year":"2008","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib649","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1600-0420.2005.00582.x","article-title":"Clinical characteristics of subretinal deposits in central serous chorioretinopathy","volume":"83","author":"Wang","year":"2005","journal-title":"Acta Ophthalmol. Scandinavica"},{"key":"10.1016\/j.preteyeres.2024.101236_bib650","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1034\/j.1600-0420.1999.770408.x","article-title":"Detection of shallow detachments in central serous chorioretinopathy","volume":"77","author":"Wang","year":"1999","journal-title":"Acta Ophthalmol. Scandinavica"},{"key":"10.1016\/j.preteyeres.2024.101236_bib651","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0002-9394(02)01438-1","article-title":"Retinal atrophy in idiopathic central serous chorioretinopathy","volume":"133","author":"Wang","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib652","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/IAE.0b013e3182953df4","article-title":"Pachychoroid pigment epitheliopathy","volume":"33","author":"Warrow","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib653","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0002-9394(99)00320-7","article-title":"Serous retinal detachment at the macula in sarcoidosis","volume":"129","author":"Watts","year":"2000","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib654","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000050855","article-title":"Familial chronic central serous chorioretinopathy","volume":"215","author":"Weenink","year":"2001","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2024.101236_bib655","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3928\/1542-8877-20050901-11","article-title":"Transpupillary thermotherapy in the treatment of central serous chorioretinopathy","volume":"36","author":"Wei","year":"2005","journal-title":"Ophthal. Surg., Lasers Imag."},{"key":"10.1016\/j.preteyeres.2024.101236_bib656","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1126\/science.7123248","article-title":"Type a behavior and elevated physiological and neuroendocrine responses to cognitive tasks","volume":"218","author":"Williams","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2024.101236_bib657","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1023\/A:1002496223131","article-title":"Inhibition of membrane-bound carbonic anhydrase decreases subretinal ph and volume","volume":"97","author":"Wolfensberger","year":"1999","journal-title":"Docum. Ophthalmol. Adv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib658","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/sj.eye.6700637","article-title":"Five to 15 year follow-up of resolved idiopathic central serous chorioretinopathy","volume":"18","author":"Wong","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib659","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/ICB.0b013e31824f7130","article-title":"Bilateral drug (ipilimumab)-induced vitritis, choroiditis, and serous retinal detachments suggestive of vogt-koyanagi-harada syndrome","volume":"6","author":"Wong","year":"2012","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib660","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.preteyeres.2024.101236_bib661","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/IAE.0000000000001386","article-title":"Nondamaging laser therapy for treatment of central serous chorioretinopathy: what is the evidence?","volume":"37","author":"Wood","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib662","doi-asserted-by":"crossref","first-page":"9040","DOI":"10.1038\/s41598-019-45080-8","article-title":"Optical coherence tomography angiography for diagnosis of choroidal neovascularization in chronic central serous chorioretinopathy after photodynamic therapy","volume":"9","author":"Wu","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib663","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/OPX.0000000000001394","article-title":"Combined topical anti-inflammatory and oral acetazolamide in the treatment of central serious chorioretinopathy","volume":"96","author":"Wuarin","year":"2019","journal-title":"Optometry Vis. Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib664","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00006982-198808040-00003","article-title":"Indirect choroidal rupture secondary to blunt ocular trauma. A review of eight eyes","volume":"8","author":"Wyszynski","year":"1988","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib665","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/eye.2014.315","article-title":"Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome","volume":"29","author":"Yadav","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib666","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/IAE.0b013e31802f6ef6","article-title":"Serous retinal detachment secondary to choroidal osteoma successfully treated with transpupillary thermotherapy","volume":"2","author":"Yahia","year":"2008","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.preteyeres.2024.101236_bib667","doi-asserted-by":"crossref","DOI":"10.1007\/s10384-023-00978-9","article-title":"Practical treatment options for persistent central serous chorioretinopathy and early visual and anatomical outcomes","author":"Yamada-Okahara","year":"2023","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib668","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10384-020-00773-w","article-title":"Hypothetical pathogenesis of age-related macular degeneration and pachychoroid diseases derived from their genetic characteristics","volume":"64","author":"Yamashiro","year":"2020","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib669","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11154614","article-title":"Relationship between pachychoroid and polypoidal choroidal vasculopathy","volume":"11","author":"Yamashiro","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2024.101236_bib670","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1167\/iovs.12-10991","article-title":"Optical coherence tomography\u2013assisted enhanced depth imaging of central serous chorioretinopathy","volume":"54","author":"Yang","year":"2013","journal-title":"Investig. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib671","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00006982-198700720-00009","article-title":"Type-a behavior and central serous chorioretinopathy","volume":"7","author":"Yannuzzi","year":"1987","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib672","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ajo.2009.11.017","article-title":"Central serous chorioretinopathy: a personal perspective","volume":"149","author":"Yannuzzi","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib673","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1001\/archopht.1991.01080100091049","article-title":"Unilateral acute idiopathic maculopathy","volume":"109","author":"Yannuzzi","year":"1991","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib674","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/S0161-6420(84)34117-3","article-title":"Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy","volume":"91","author":"Yannuzzi","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101236_bib675","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00006982-200306000-00002","article-title":"Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study","volume":"23","author":"Yannuzzi","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib676","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","article-title":"Idiopathic polypoidal choroidal vasculopathy (ipcv)","volume":"10","author":"Yannuzzi","year":"1990","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib677","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/archopht.1996.01100130681007","article-title":"The long-term outcome of central serous chorioretinopathy","volume":"114","author":"Yap","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib678","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00417-016-3441-8","article-title":"Retinal sensitivity after selective retina therapy (srt) on patients with central serous chorioretinopathy","volume":"255","author":"Yasui","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib679","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/02713683.2013.824986","article-title":"Obstructive sleep apnea in patients with central serous chorioretinopathy","volume":"39","author":"Yavas","year":"2014","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101236_bib680","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7217906","article-title":"Choroidal neovascularization secondary to central serous chorioretinopathy: oct angiography findings and risk factors","volume":"2020","author":"Yeo","year":"2020","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib681","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/IAE.0000000000003692","article-title":"Distinct characteristics of simple versus complex central serous chorioretinopathy","volume":"43","author":"Yoneyama","year":"2023","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101236_bib682","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ajo.2014.06.015","article-title":"Study of subretinal exudation and consequent changes in acute central serous chorioretinopathy by optical coherence tomography","volume":"158","author":"Yu","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib683","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12886-019-1089-y","article-title":"The relationship between foveal outer nuclear layer thickness in the active and resolved phases of central serous chorioretinopathy treated with half-dose photodynamic therapy","volume":"19","author":"Yu","year":"2019","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib684","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5580075","article-title":"Clinical characteristics of pregnancy-associated central serous chorioretinopathy in the Chinese population","volume":"2021","author":"Yu","year":"2021","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib685","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5970659","article-title":"Risk factors for persistent or recurrent central serous chorioretinopathy","author":"Yu","year":"2019","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib686","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s41433-020-1018-6","article-title":"Relationship between photoreceptor layer changes before half-dose photodynamic therapy and functional and anatomic outcomes in central serous chorioretinopathy","volume":"35","author":"Yu","year":"2021","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101236_bib687","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s00417-016-3315-0","article-title":"Clinical efficiency of helicobacter pylori eradication in the treatment of patients with acute central serous chorioretinopathy","volume":"254","author":"Zavoloka","year":"2016","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib688","article-title":"And oct angiography update: clinical application to age-related macular degeneration, central serous chorioretinopathy, macular telangiectasia, and diabetic retinopathy","volume":"13","author":"Zhang","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.preteyeres.2024.101236_bib689","first-page":"543","article-title":"Effect of central serous chorioretinopathy patients by covering sick eye for 48 hours","volume":"84","author":"Zhao","year":"2021","journal-title":"Arqu. Brasil. Oftalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib690","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","article-title":"Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy","volume":"122","author":"Zhao","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.preteyeres.2024.101236_bib691","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1096\/fj.09-154344","article-title":"The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in muller glial cells","volume":"24","author":"Zhao","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.preteyeres.2024.101236_bib692","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jamaophthalmol.2014.5312","article-title":"A 50 % vs 30 % dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trial","volume":"133","author":"Zhao","year":"2015","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib693","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7792291","article-title":"Efficacy of navigated laser photocoagulation for chronic central serous chorioretinopathy: a retrospective observational study","volume":"2022","author":"Zhou","year":"2022","journal-title":"Dis Markers"},{"key":"10.1016\/j.preteyeres.2024.101236_bib694","doi-asserted-by":"crossref","DOI":"10.1007\/s10103-019-02721-8","article-title":"A pilot prospective study of 577-nm yellow subthreshold micropulse laser treatment with two different power settings for acute central serous chorioretinopathy","author":"Zhou","year":"2019","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.preteyeres.2024.101236_bib695","article-title":"Subthreshold micropulse laser vs. Conventional laser for central serous chorioretinopathy: a randomized controlled clinical trial","volume":"8","author":"Zhou","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.preteyeres.2024.101236_bib696","first-page":"1784","article-title":"Risk factors for incident central serous retinopathy: case-control analysis of a us national managed care population","volume":"103","author":"Zhou","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib697","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2022-000976","article-title":"Risk factors and characteristics of central serous chorioretinopathy with later development of macular neovascularisation detected on oct angiography: a retrospective multicentre observational study","volume":"7","author":"Zhou","year":"2022","journal-title":"BMJ Open Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib698","doi-asserted-by":"crossref","DOI":"10.1111\/aos.13742","article-title":"Evolution of fundus autofluorescence patterns over time in patients with chronic central serous chorioretinopathy","author":"Zola","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101236_bib699","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40123-018-0121-2","article-title":"Eplerenone versus observation in the treatment of acute central serous chorioretinopathy: a retrospective controlled study","volume":"7","author":"Zucchiatti","year":"2018","journal-title":"Ophthalmol. Ther."}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946224000016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946224000016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T15:41:54Z","timestamp":1731166914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946224000016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":699,"alternative-id":["S1350946224000016"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2024.101236","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central serous chorioretinopathy: An evidence-based treatment guideline","name":"articletitle","label":"Article Title"},{"value":"Progress in Retinal and Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preteyeres.2024.101236","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101236"}}